CA2221190C - Novel substituted taxanes and pharmaceutical compositions containing them - Google Patents

Novel substituted taxanes and pharmaceutical compositions containing them Download PDF

Info

Publication number
CA2221190C
CA2221190C CA002221190A CA2221190A CA2221190C CA 2221190 C CA2221190 C CA 2221190C CA 002221190 A CA002221190 A CA 002221190A CA 2221190 A CA2221190 A CA 2221190A CA 2221190 C CA2221190 C CA 2221190C
Authority
CA
Canada
Prior art keywords
solution
mixture
taxol
aromatic
thf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002221190A
Other languages
French (fr)
Other versions
CA2221190A1 (en
Inventor
Robert A. Holton
Ronald J. Biediger
Hossain Nadizadeh
Soekchan Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Florida State University
Original Assignee
Florida State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florida State University filed Critical Florida State University
Publication of CA2221190A1 publication Critical patent/CA2221190A1/en
Application granted granted Critical
Publication of CA2221190C publication Critical patent/CA2221190C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/003Compounds containing elements of Groups 4 or 14 of the Periodic System without C-Metal linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

The invention relates to a .beta.-lactam of the formula (see fig. I) wherein R1 and R3 are independently selected from phenyl, naphthyl, C6H5CHCH-, and (see fig. II) (see fig. III) or (see fig. IV) Q is CH3-, (CH3)3C-, CH3)-, Cl, Br, F, or NO2; and R2 is hydrogen or hydroxy protecting group. The .beta.-lactams are useful as intermediates in the preparation of a taxane derivative of the formula (see fig. IV) wherein R1 and R3 are independently selected from the group comprising phenyl, naphthalene, C6H5CHCH-, (see fig. V), (see fig. VI) and (see fig. VII) provided, however, R1 and R3 are not both phenyl;

Q is CH3-, (CH3)3C-, CH3O-, Cl, Br, F, or NO2;

Z is -OT1;
T1 is hydrogen, hydroxyl protecting group, or -COT2;
T2 is H, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl or monocylic aryl;
Ac is acetyl; and E1 and E2 are independently selected from hydrogen and functional groups which increase the water solubility of the taxane derivative are useful as antitumor agents.

Description

NOVEL SUBSTITUTED TAXANES AND
PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BACKGROUND OF THE INVENTION
The present divisional application is divided out of parent application Serial No. 2,077,394 filed on September 2, 1992.
The invention of the parent application relates to novel taxanes which have utility as antileukemia and antitumor agents.
The invention of the present divisional application relates to certain beta-lactams useful as intermediates in the preparation of the taxanes of the parent application.
The taxane family of terpenes, of which taxol is a member, has attracted considerable interest in both the biological and chemical arts. Taxol* is a promising cancer chemotherapeutic agent with a broad spectrum of antileukemic and tumor-inhibiting activity. Taxol has a 2'R, 3'S
configuration and the following structural formula:
2 o OAc OH
(1) *Trade-mark wherein Ac is acetyl. Because of this promising activity, taxol is currently undergoing clinical trials in both France and the United States.
Colin et al. reported in U.S. Patent No. 4,814,470 that taxol derivatives having structural formula (2) below, have an activity significantly greater than that of taxol (1).
R'O
__ _ _ ~~ / I I
~-R. , 2 ' ' Y = \0 ~5-~-R~ . . ~H H
~3 i ~6H5 R' represents hydrogen or acetyl and one of R " and R " ' represents hydroxy and the other represents tert-butoxy-carbonylamino and their stereoisomeric forms, and mixtures thereof. The compound of formula (2) in which R' is hydrogen, R " is hydroxy, R " ' is tert-butoxycarbonylamino having the 2'R, 3'S configuration is commonly referred to as taxotere.
Although taxol and taxotere are promising chemotherapeutic agents, they are not universally effective.
Accordingly, a need remains for additional chemotherapeutic agent s .
SUMMARY OF THE INVENTION
Among the objects of the present invention, therefore, is the provision of novel taxane derivatives which 2a are valuable antileukemia and antitumor agents.
Briefly, therefore, one aspect of the invention of the parent application is directed to taxane derivatives of the formula:

I
3 2 1 I ~ 9 1 OEz N ~O""" I14 I ~ ( ) ~ IG

OH
CbHsC00 wherein R1 and R3 are independently selected from the group consisting of phenyl, naphthyl, C6H5CEiCH-, and and Q ~ , 'O

provided, however, R1 and R3 are not both phenyl]
Q is CH3-, (CH3}3C-, CH30-, C1, Hr, F, or -N02~
Z 1s -OT1~
T1 is hydrogen, hydroxyl protecting group, or -COT2s T2 1s H, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl or monocyclic aryls Ac is acetyl; and E1 and E2 are independently selected from hydrogen, and functional groups which increase the water solubility of the taxane derivative.
Other ob~ects and features of this invention will 64725-55fl be in part apparent and in part pointed out hereinafter.
According to one aspect of the present divisional application there is provided a ~i-lactam of the formula O
O
R3 IV ~ 2 R~ OR2 wherein R1 and R3 are independently selected from phenyl, naphthyl, C6HSCHCH-, and o~ 1~~

O ~ \OCH3 Q is CH3-, (CH3) 3C-, CH30-, Cl, Br, F, or N02; and R2 is hydrogen or hydroxy protecting group.
According to another aspect of the present divisional application there is provided a process for the preparation of a ,Q-lactam of the formula 4a O
O

4 3 (4) or an enantiomer or diastereoisomer thereof, which process comprises cyclocondensing a compound having the structure H O-M
(II) R2- O-C=C-OR22 with an imine having the structure R1-C=N-R11 (III) to form an azetidine having the structure O

4 3 (N), and treating said azetidine with an acyl chloride of formula R3C(O)Cl in the presence of a base to form the a-lactam of formula (4), wherein R1 and R3 are independently selected from phenyl , naphthyl , C6HSCHCH- , and 4b O \OCH3 ' Q is CH3-, (CH3) 3C-, CH30-, C1, Br, F, or N02; and R2 is hydrogen or hydroxy protecting group; Rll is trialkylsilyl or triarylsilyl; R22 is alkyl; and M is metal.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
It has been discovered that compounds having structural formula (3) show remarkable properties, in vitro, and are valuable antileukemia and antitumor agents. Their biological activity has been determined in vitro, using tubulin assays according to the method of Parness et al., J. Cell Biology, 91: 479-487 (1981) and human cancer cell lines, and is comparable to that exhibited by taxol and taxotere.
Taxane derivatives having formula (3) may be obtained by reacting a ~3-lactam with metal alkoxides having the taxane tetracyclic nucleus and a C-l3 metallic oxide substituent to form compounds having a ~i-amido ester substituent at C-13. The ~i-lactams have the following structural formula:
O
O
R3 N~

R~ OR2 ' 64725-558D
4c wherein R1 and R3 are as previously defined, and Rz is a hydroxy protecting group, a-lactams (4) can be prepared from readily available starting materials, as is illustrated by the following reaction scheme:

0 oLi a f25S:E0 OCEEzCEf3 __ ~ RSS10 O( N-TrlS
ArCHO ~ Ar-~/
C
H\ O
N~ a d N 2 \\\\\\\\ //////// \\\\\\ //////
Ar OS i R5 \ /
Ar OS i R5 reagents 5 (a) LDA, THF, -78°C to -50°C;
(b) LHMDS, THF, -78°C to 0°C;
(c) THF, -78°C to 25°C, (2h); and (d) triethylamine and an acyl chloride I~3 ~O or C,~ ~ n The 3-hydroxyl protecting group shown in the above reaction scheme is -SIRS wherein R5 is trialkyl or triaryl such as triethyl. The 3-hydroxyl may be protected with other standard protecting groups such as 1-etlioxy-ethyl, or 2,2,2-trichloroethoxymethyl. Additional hydroxy protecting groups and the synthesis thereof may be found in "Protective groups in Organic Synthesis" by T.W. Greene, John Wiley & Sons, 1981.
The racemic B-lactams may be resolved into the pure enantiomers prior to protection by recrystallization of the corresponding 2-methoxy-2-(trifluoromethyl) phenylacetic esters. However, the reaction described hereinbelow in which the (3-amido ester side chain is attached has the advantage of being highly diastereo-selective, thus permitting the use of a racemic mixture of side chain precursor.
The metal alkoxides having the taxane tetracyclic nucleus and a C-13 metallic oxide substituent have the following structural formula:

MOilni( i t10 _ PhG00 ''~' Ac0'~~O
(5) wiuerein Z is -OT,; T~ is hydrogen, hydroxyl protecting group, or -COT2; Tz i.s II, C~-C6 alkyl, C2-Ce al.kenyl, Cz-C6 alkynyl or monocylic aryl; T3 is a hydroxy protecting group;
and M is a metal, preferably selected from the group comprising Group IA, Group IIA and transition metals, and most preferably, Li, Mg, Na, K or Ti.
The metal alkoxides are prepared by reacting an alcohol having the taxane tetracyclic nucleus and a C-13 hydroxyl group with an organornetallic cornpound in a suitable solvent. Preferably, the alCOho1 is a protected baccatin III, in particular, 7--O-triethylsi.lyl. baccatin III
(wtnich can be obtained as described by Greene, et al. in .1ACS 110: 5917 (1988) or by other routes) or 7,10-bis-O-trietliylsi.l.yl baccatin TII.
As reported in Greene et al., 10-deacetyl baccatin III is converted to 7-O-triethylsilyl-10-deacetyl baccatin III according to the following reaction scheme:
OH
CH3 '~ OH OR
to-'~CHa CH3 ~ '~ Os1(Cafi3)3 ~ O ~ i3 'H3 ~ 1. (C~ti~)~81C1, C~ttsH ' -f!O -- 1 3 _ - H3 ' CH3 ~ 2. Ctf~COCl. C~rlyN HO -- 1 3 ' ~~CH3~ , OH ~ H 'I
OCOCaHsOCOCH3 OH ; H

OCOC6 H~
(6) (7) a, Tl=H
b, T1=COCH3 Under what is reported to be carefully optimized conditions, 10-deacetyl baccatin III is reacted with 20 equivalents of (C2f~5)3SiC1 at 23°C under an argon l0 atmosphere for 20 hours in the presence of 50 ml of pyridine/mmol of 10-deacetyl baccatin III to provide 7-triethylsilyl-10-deacetyl baccatin III (7a) as a reaction product in 84-86% yield after purification. The reaction product may then optionally be acetylated with 5 equivalents of CH3COC1 and 25 rnl. of pyridine/lnrnol of 7a at 0 °C under an argon atmosphere for 48 hours to provide 86%
yield of 7-O-triethylsilyl baccatin III (7b). Greene, et al. in JACS 110_, 5917 at 5918 (1988).
The 7-O-triethylsilyl baccatin III (7b) is reacted with an organometallic compound such as n-butyllithium in a solvent such as tetrahydrofuran (THF), to form the metal alkoxide 13-O-lithium-7-O-triethylsilyl baccatin III (8) as shown in the following reaction scheme:
OR
Ci~3 O
~o~~/
- H Cii3 OSi(CZii5)3 CH3CH2CHzCH2Li + HO-- ~
'~CH-,~
OH ~ H :I
c THF

'°~~Cii3 OS1(CZHS)3 CH3CH2CHzCH3 + Li0-- ~3 H3 '~CH~~ ( OH ~ H

As shown in the Following reaction scheme, 13-O-lithium-7-O-triethylsilyl baccatin III (8) reacts with f3-lactam (4) in which R2 is triethylsilyl to provide an LO intermediate in which the C-7 and C-2' hydroxyl groups axe protected with a triethylsilyl. group. 'the triethylsilyl groups are then hydrolyzed under mild conditions so as not to disturb the ester linkage or the taxane substituents.
OTES O
/ (i) ~ R3 N _ O..
Li0""" , R ~ O
(2) HF, Pyridine, CH3CH H HO
HO
PhC00 R1 OTES
(l0) (4) wherein R1 and R3 are as previously defined, Ac0 Ac is acetyl, TES is triethylsilyl and Ph is phenyl.
Both the conversion of the alcohol to the metal alkoxide and the ultimate synthesis of the taxane derivative can take place in the same reaction vessel. Preferably, the ~i-lactam is added to the reaction vessel after formation therein of the metal alkoxide.
There is also provided pharmaceutical compositions containing a compound of formula (3) in combination with one or more pharmaceutically acceptable, inert or physiologically active, diluents or adjuvants.
These compositions may be presented in any form appropriate for the administration route envisaged. The parenteral route, and especially the intravenous route, is the preferential route for administration.
The compositions for parenteral administration may be aqueous or nonaqueous sterile solutions, suspensions or emulsions. Propylene glycol,wegetable oils, especially olive oil, and injectable organic esters, e.g. ethyl oleate, may be used as the solvent or the vehicle. These compositions may also 5 contain adjuvants, especially wetting agents, emulsifiers or dispersants. The sterilization may be carried out in several ways, e.g. using a bacteriological filter, by incorporating sterilizing agents into the composition, by irradiation or by heating. They may also be in tire form of 10 sterile solid compositions which may be dissolved or dispersed in sterile water or any other injectable sterile medium.
The products of general formula (3) are more particularly used in the treatment of acute leukemias and solid tumors, at daily doses which are generally between 1 and 2 mg/kg by the intravenous (perfusion) route for an adult.
The water solubility of compounds of formula (3) may be improved by modificat=i.on of the C2' and/or C7 substituerrts to incorporate appropriate fmncti.onal groups, Ei and Ez. For increased water solubility, Er and EZ may independently be hydrogen and -COGCOR' wherein:
G is ethylene, propylene, CIICIi, 1, 2-cyclo-hexylene, or 1,2-phenylene;
R' - OH base, NRZR3, OR', SR', OCLi2CONR4R5, or OII;
RZ - hydrogen or methyl;
R' - (Cllz) "NR6R~~ or (Cliz) "NRm~R~ReX";
n - 1 to 3;
R1 - hydrogen or lower alkyl co»taini.ng 1 to 4 carbons;
RS - hydrogen, lower alkyl containing 1 to 4 carbons, benzyl, tydroxyethyl , CLIzCO2Ii, or dimet=my lami noethy 1 ;
R6 and R' - independent;ly se:lecteci from lower alkyl containing 1 or 2 carbons or benzyl, or R6 and R' together with tl~e nitrogen atom of NR6R7 forms one of the following rings N N N N N
or ;
O S N
I

R8 - lower alkyl containing 1 or 2 carbons or benzyl;
Xe - halide; and base = NH3, (HOC2H4)3N, N(CH3)3, CH3N(C2H40H)2, NH2(CH2)6NH2, N-methylglucamine, NaOH, or KOH.
The preparation of compounds in which E1 or E2 is -COGCOR1 is set forth in Hangwitz U.S. patent 4,942,184.
The following examples illustrate the invention of both the parent application and the present divisional application.

Ac O P1 i O
OH
Ph N O"""
I .,, , H OH
HO
Ph C~
Ac0\ O
O
wherein Npl is Preparation of 3'-desphenyl-3'-(1-naphthyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-1-benzoyl-3-triethylsilyloxy-4-(1-naphthyl)azetidin-2-one (620 mg, 1.43 mmol) in 2 mL of THF
was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10$ solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous Na~iC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 325 mg of a mixture containing (2'R,3'S)-2',7-(bis)-triethylsilyl-3'-desphenyl-3'-(1-naphthyl.) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 325 mg (0.287 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48~
aqueous HF. The mixture was stirred at 0 °C for 3 h, then at °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 260 mg of material which was purified by flash chromatography to give 166 mg (64$) of 3'-(1-naphthyl) taxol, which was recrystallized from methanol/-water.

' 13 m. p. 164-165 °C; [a]25NA-52.6° (c 0.005, CHC13).
1H NMR (CDC13, 300 MHz) d 8.11 (d, J = 7.1 Hz, 2H, benzoate ortho), 8.11 (m, 3H, aromatic), 7.91 (m, 3H, aromatic), 7.70 (m, 2H, aromatic), 7.63-7.46 (m, 7H, aromatic), 6.75 (d, J =
8.8 Hz, 1H, NH), 6.52 (dd, J = 8.8, 1.6 Hz, 1H, H3'), 6.27 (s, 1H, H10), 6.27 (dd, J = 9.1, 9.1 Hz, 1H, H13), 5.68 (d, J = 7.1 Hz, 1H, H2s), 4.85 (dd, J = 7.6, 2.2 Hz, lEi, H5), 4.97 (dd, J = 1.6 Hz, 1H, H2'), 4.39 (m, 1H, H7), 4.24 (d, J = 8.5 Ffz, 1H, H20a), 4.17 (d, = Hz, 1H, H20S), 3.80 J 8.S

(d, J = 7.1 Hz, 1H, H3), 3.65 (br, 1H, 2'OH), 2.55 1H, (m, H6a), 2.48 (br, 1H, 70H), 2.41 (s, 3H, 4Ac), 2.38 (m, 1H, f-fl4) , 1.96 (s, 3H, lOAc) , 1.86 (m, 1H, H6S) , 1.80 (br s, 3H, MelB), 1.76 (s, 1H, lOH), 1.69 (s, 3H, Mel9), 1.28 (s, 3H, Mel7), 1.16 (s, 3H, Mel6).
LTV T AAT1T T'.~ '1 OAc O Np2 O
)H
Ph N O~ii~in H OH
Ph ~~O
wherein Np2 is Preparation of 3'-desphenyl-3'-(2-naphthyl) taxol.

To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-1-benzoyl-3-triethylsilyloxy-4-(2-naphthyl)acetidin-2-one (620 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C
and kept at that temperature for 1 h before 1 mL of a 10$
solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane.
Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 320 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-3'-desphenyl-3'-(2-naphthyl) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 320 mg (0.283 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48$ aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 255 mg of material which was purified by flash chromatography to give 166 mg (64$) of 3'-desphenyl-3'-(2-naphthyl) taxol, which was recrystallized from methanol/water.
m. p. 164-165 °C; [a]25Na-52.6° (c 0.005, CHC13).
1H NMR (CDC13, 300 MHz) d 8.14 (d, J = 7.3 Hz, 2H, benzoate ortho), 7.96 (m, 1H, aromatic), 7.90 (m, 1H, aromatic), 7.85 (m, 2H, aromatic), 7.76 (m, 2H, aromatic), 7.60 (m, 3H, aromatic), 7.52 (m, 4ii, aromatic), 7.41 (m, 2H, aromatic), 7.01 (d, J = 8.8 Hz, 1H, NH) , 6.27 (s, lii, H10) , 6.26 (dd, J = 9.2, 9.2 Hz, 1H, H13), 5.97 (dd, J = 8.8, 2.5 Hz, 1H, H3'), 5.68 (d, J = 7.1 Hz, 1H, H2S), 4.93 (m, 1H, H5), 4.92 (m, 1H, H2'), 4.39 (m, 1H, H7), 4.30 (d, J = 8.5 Hz, 1H H20a), 4.20 (d, J = 8.5 Hz, 1H, H20S), 3.81 (d, J = 7.1 Hz, 1H, H3), 3.60 (d, J = 5 Hz, 1H, 2'OH), 2.48 (m, 1H, H6a), 2.45 (br, 1H, 70H), 2.39 (s, 3H, 4Ac), 2.30 (m, 2H, H14), 2.24 (s, 3H, lOAc), 1.83 (m, 1H, H6S) , 1.82 (br s, 3H, Mel8) , 1.68 (s, lii, lOii) , 1.68 10 (s, 3H, Mel9), 1.24 (s, 3H, Mel7), 1.14 (s, 3H, Mel6).
LTV T ~.1TT T "f OAc O ~ O
)H
Ph N O~~~i H OH
Preparation of 3'-desphenyl-3'-(4-methoxyphenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-1-benzoyl-3-tri.ethylsilyloxy-4-(4-methoxyphenyl)azetidin-2-one (590 mg, 1.43 mmol) in 2 mh of THF was added dropwise to the mixture. The solution was Ph~ Ac0 ~~O

warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10~ solution of AcOII in THE' was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 320 mg of a mixture containing (2'R,3'S)-2',7-(bis)-triethylsilyl-3'-desphenyl-3'-(4-methoxyphenyl) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 320 mg (0.288 mmol) of the mixture obtained from the previous reaction in 18 rnL of acetonitrile and 0.93 mI. of pyridine at 0 °C was added 2.8 m1. of 48$ aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C
for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 255 mg of material which was purified by flash chromatography to give 172 mg (68$) of 3'-desphenyl-3'-(4-methoxyphenyl) taxol, which was recrystallized from methanol/water.
m. p. 174-176 °C; [a]25Na-48.86° (c 0.05, CEiCl3).
1fI NMR (CDC13, 300 MI3z) 8 8.12 (d, J = 7.1 iiz, 2H, benzoate ortho), 7.72 (m, 2H, aromatic), 7.59 (m, 1H, aromatic), 7.53-7.36 (m, 8H, aromatic), 6.96 (d, J = 8.8 Hz, 1H, NH), 6.90 (m, 2H, aromatic), 6.26 (s, 1H, H10), 6.21 (dd, J = 9.3, 9.3 Hz, 1H, Iil3) , 5. 70 (dd, J = 8.8, 2. 7 Hz, ltE, H3' ) , 5.66 (d, J = 6.8 Hz, 1H, H2S), 4.93 (dd, J = 9.9, 2.2 Hz, 1H, H5), 4 . 74 (dd, J = 5. 5, 2 . 7 Hz, 1H, H2' ) , 4 . 39 (m, 1H, H7 ) , 4 . 29 (d, J = 8. 8 Hz, 1H, H20a) , 4.18 (d, J = 8.8 Hz, 1H, II20S) , 3.78 (d, J = 6.8 fiz, 1H, fi3) , 3.78 (s, 3H, ArOMe) , 3.67 (d, J = 5.5 Hz, 1H, 2'OH), 2.61 (m, 1H, H6a), 2.50 (d, J = 4.4 Hz, 1H, 70H), 2.37 (s, 3H, 4Ac), 2.31 (m, 2H, H14), 2.22 (s, 3H, lOAc), 1.84 (m, 1H, H6S), 1.79 (br s, 3H, Mel8), 1.79 (s, 1H, lOH), 1.67 (s, 3H, Mel9), 1.22 (s, 3H, Mel7), 1.13 (s, 3H, Mel6).
LTV T ~ATT r A

OAC
O \ ~ O
Ph~N H
_- Oul~~l H OH
Preparation of 3'-desphenyl-3'-(4-chlorophenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-1-benzoyl-3-triethylsil.yloxy-4-(4-chlorophenyl)azetidin-2-one (595 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10$ solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NafiC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic 1_ayer gave a residue which was purified by filtration through silica gel to give 320 mg of a mixture containing (2'R,3'S)-2',7-(bis)-triethylsilyl-3'-desphenyl-3'-(4-chlorophenyl) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 320 mg (0.287 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48~
aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 255 mg of material which was purified by flash chromatography to give 158 mg (62~) of 3'-desphenyl-3'-(4-chlorophenyl) taxol, which was recrystallized from methanol/water.
m. p. 173-175 °C; [a]25Na-50.8° (c 0.01, CHC13).
1F~ NMR (CDC13, 300 MHz) 6 8.13 (d, J = 7.1 Hz, 2H, benzoate ortho), 7.72 (d, J = 8.2 Hz, 2H, benzamide ortho), 7.65-7.35 (m, lOFi, aromatic) , 6.97 (d, J = 8.8 Hz, lFi, NH) , 6 .27 (s, 1H, H10), 6.25 (dd, J = 8.3, 8.3 Hz, 1H, H13), 5.78 (dd, J = 8.8, 2.2 Hz, 1H, H3'), 5.67 (d, J = 7.1 Hz, 1H, H2S), 4.95 (dd, J = 8.8, 2.2 Hz, 1H, H5), 4.77 (br s, 1H, H2'), 4.40 (m, 1H, H7), 4.31 (d, J = 8.2 Hz, 1H, H20a), 4.19 (d, J = 8.2 Hz, 1H, H20S) , 3.80 (d, J = 7.1 Hz, 1H, Fi3) , 3.61 (br s, lFi, 2'OH) , 2.54 (m, 1H, H6a), 2.38 (s, 3H, 4Ac), 2.32 (m, 2H, H14), 2.24 (s, 3EI, lOAc) , 1.85 (m, 1H, Ei6 S) , 1.80 (br s, 3H, Mel8) , 1.68 (s, 3H, Mel9), 1.23 (s, 3H, Mel7), 1.14 (s, 3H, Mel6).

. T9 Br OAc O O
~N OH
Ph I _ ~~iiii~
H OH
Ph Preparation of 3'-desphenyl-3'-(4-bromophenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-1-benzoyl-3-triethylsilyloxy -4-(4-bromophenyl)azetidin-2-one (660 mg, 1.43 mmol) in 2 mL of THF was added~dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10$ solution of AcOH in THF was added. The mixture way partitioned between saturated aqueous NaiiC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 330 mg of a mixture containing (2'R,3'S)-2',7-(bis)-triethylsilyl-3'-desphenyl-3'-(4-bromophenyl) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 330 mg (0.284 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile E>4 725-558 and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48$ aqueous EIF. The mixture was stirred at 0 °C for 3 h, then at 25 °C
for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 265 mg of material which was purified by flash chromatography to give 186 mg (64~) of 3'-desphenyl-3'-(4-bromophenyl) taxol, which was recrystallized from methanol/-water.
m, p. 170-172 °C; [a]25Na-50.94° (c 0.01, CHC13).
10 1H NMR (CDC13, 300 MHz) d 8.12 (d, J = 7.2 FIz, 2EI, benzoate ortho), 7.71 (m, 2H, aromatic), 7.61 (m, 1H, aromatic), 7.50-7.47 (m, 6H, aromatic), 7.38 (m, 3H~, aromatic), 7.09 (d, J =
8.8 Hz, 1H, NH), 6.27 (s, 1H, H10), 6.23 (dd, J = 8.2, 8.2 Hz, 1H, H13), 5.75 (dd, J = 8.8, 2.2 Hz, 1H, H3'), 5.66 (d, J =
7.1 Hz, 1H, H2S) , 4.94 (dd, J = 9.3, 1.7 FIz, 1H, H5) , 4.75 (dd, J = 2.2 Hz, 1H, H2'), 4.38 (m, 1H, H7), 4.29 (d, J = 8.2 Hz, 1H, H20a), 4.18 (d, J = 8.2 Hz, 1H, H20S), 3.79 (d, J = 7.1 Hz, 1H, H3), 3.7 (br, 1H, 2'OH), 2.53 (m, 1H, H6a), 2.38 (br, 1H, 70H), 2.37 (s~ 3H, 4Ac), 2.30 (m, 2H, H14), 2.23 (s, 3H, lOAc), 20 1.87 (m, 1H, H6S) , 1.80 (br s, 3Fi, Mel8) , 1.80 (s, 1H, lOH) , 1.67 (s, 3H, Mel9) , 1.22 (s, 3H, Mel7) , 1.13 (s, 3H, Mel_6) .

F~rantnr ~ ~
O~O
OAc O ~ O O
OH
Ph N OI 1 W n , HO = H
O
Ac O~ O
Ph O
Preparation of 3'-desphenyl-3'-(3,4-methylenedioxy-phenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-1-benzoyl-3-triethylsilyloxy-4-(3,4-methylenedioxyphenyl)azetidin-2-one (610 mg, 1.43 mmol) in 2 mL of TfiF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10$ solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 320 mg of a mixture containing (2'R,3'S)-2',7-(bis)-triethylsilyl-3'-desphenyl-3'-(3,4-methylenedioxyphenyl) taxol and a small amount of the (2'S,3'R) isomer.

To a solution of 320 mg (0.284 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitr_ile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48~ aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 113 mg of material which was purified by flash chromatography to give 165 mg (64~) of 3'-desphenyl-3'-(3,4-methylenedioxyphenyl) taxol, which was recrystallized from methanol/water.
m. p. 178-180 °C; [a]25Na-46.6° (c 0.005, CHC13).
1H NMR (CDC13, 300 MHz) d 8.14 (d, J = 7.2 Hz, 2H, benzoate ortho), 7.72 (m, 2H, aromatic), 7.15 (m, 1H, aromatic), 7.50 (m, 2II, aromatic) , 7. 38 (m, 2Ii, aromatic) , 7.0 (m, lII, aromatic), 6.94 (m, 2H, aromatic), 6.88 (d, J = 9.1 Hz, 1H, NH), 6.83 (m, 1H, aromatic), 6.28 (s, 1H, H10), 6.23 (dd, J =
9.1, 9. 1 Iiz, 1H, H13) , 5.97 (s, 2H, methylene) , 5.69 (dd, J =
9.1, 2.5 Hz, 1H, H3'), 5.68 (d, J = 6.9 Hz, 1H, H2S), 4.95 (dd, ,7 = 9.6, 2.2 Hz, 1H, H5) , 4 : 72 (dd, J = 2. 5 IIz, 1H, Ii2' ) , 4.91 (m, 1H, H7), 4.31 (d, J = 8.4 Hz, 1H, H20a), 4.20 (d, J = 8.4 Hz, 1H, H20S), 3.81 (d, J = 6.9 Hz, 1H, H3), 3.60 (br, 1H, 2'OH) , 2.56 (m, 1H, H6a)', 2.43 (d, J = 4. 1 Hz, lli, 70H) , 2.39 (s, 3H, 4Ac) , 2.31 (m, 2H, H14) , 2.24 (s, 3II, 1_OAc) , 1.88 (m, 1H, H6S), 1.82 (br s, 3H, Mel8), 1.69 (s, 1H, lOH), 1.68 (s, 3H, Mel9), 1.24 (s, 3H, Mel7), 1.15 (s, 3H, Mel6).

OAc ~N
Ph ~ - O~iiiii~~~ OH
..
H OH
HO _ H~s O
....
Ph-~ AcO

Preparation of 3'-desphenyl-3'-(3,4-dimethoxyphenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-1-benzoyl-3-triethylsilyloxy-4-(3,4-dimethoxyphenyl)azetidin-2-one (630 mg, 1.43 mmol) in 2 mL of THk' was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10~ solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 330 mg of a mixture containing (2'R,3'S)-2',7-(bis)-triethylsilyl-3'-desphenyl-3'-(3,4-dimethoxyphenyl) taxol and a small amount of the (2'S,3'R) isomer.

To a solution of 330 mg (0.286 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48% aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 260 mg of material which was purified by flash chromatography to give 175 mg (67%) of 3'-desphenyl-3'-(3,4-dimethoxyphenyl) taxol, which was recrystallized from methanol/water.
m. p. 165-167 °C; (a)25Na-42.0° (c 0.005, CHC13).
1H NMR (CDC13, 300 MHz) d 8.12 (d, J = 8.3 Hz, 2H, benzoate ortho), 7.73 (d, J = 8.2 Hz, 2ii, benzamide ortho), 7.65-7.35 (m, 6H, aromatic), 7.1-7.0 (m, 2H, aromatic), 6.94 (d, J = 8.8 Hz, 1H, Nii) , 6.88 (d, J = 8.3 Hz, 2H, aromatic) , 6. 27 (s, lii, H10), 6.21 (dd, J = 9.3, 9.3 Hz, 1H, H13), 5.69 (m, 2H, H3, H2S), 4.94 (dd, J = 9.9, 2.2 Hz, 1H, H5), 4.77 (d, J = 2.8 iiz, 1H, H2'), 4.39 (dd, J = 11.0, 6.6 Hz, 1H, H7), 4.30 (d, J = 8.5 Hz, 1H, H20a), 4.19 (d, J = 8.5 Hz, 1H, H20S), 3.88 (s, 3H, ArOMe), 3.87 (s, 3H, ArOMe), 3.80 (d, J = 7.1 Hz, 1H, H3) , 3.59 (d, J = 4.4 Hz, 1H, 2'OH) , 2. 54 (m, 1H, H6a) , 2. 38 (s, 3H, 4Ac) , 2.36 (m, 2H, Fil4a, H14S) , 2.23 (s, 3H, lOAc) , 1.86 (m, 1H, H6S), 1.80 (br s, 3H, Mel8), 1.68 (s, 3H, Mel9), 1.23 (s, 3H, Mel7), 1.14 ('s, 3H, Mel6).

z5 ~'YTMT)T~L~ Q

0 ~ O
N w, Ph I = O annul H OH
Preparation of 3'-desphenyl-3'-(4-nitrophenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-1-benzoyl-3-triethylsilyloxy-4-(4-nitrophenyl)azetidin-2-one (610 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10~ solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 320 mg of a mixture containing (2'R,3'S)-2',7-(bis)-triethylsilyl-3'-desphenyl-3'-(4-nitrophenyl) taxol and a small amount of the (2'S,3'R) isomer.

Pt. 'O ~,~"

To a solution of 320 mg (0.284 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48~
aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 255 mg of material which was purified by flash chromatography to give 197 mg (57$) of 3'-desphenyl-3'-(4-nitrophenyl) taxol, which was recrystallized from methanol/water.
m. p. 188-190 °C; [a)25Na-63.7° (c 0.01, CiiCl3).
1H NMR (CDC13, 300 MHz) d 8.26 (d, J = 8.8 Hz, 2H, benzoate ortho), 8.20 (m, 2H, aromatic), 7.73 (m, 4iI, aromatic), 7.60 (m, 1H, aromatic), 7.52 (m, 4H, aromatic), 7.41 (m, 1H, aromatic) , 7.15 (d, J = 8.8 Hz, 1H, 1'IH) , 6.26 (s, 1H, H10) , 6.26 (dd, J = 9.3, 9.3 Hz, 1H, H13), 5.93 (dd, J = 8.8, 2.8 Hz, lii, H3'), 5.66 (d, J = 6.6 Hz, 1H, H2S), 4.94 (dd, J =
9.3, 1.7 iiz, 1H, H5) , 4.82 (dd, J = 3.9, 2.8 Hz, 1H, H2' ) , 4.38 (m, 1H, H7), 4.30 (d, J = 8.8 Hz, 1H, H20a), 4.19 (d, J = 8.8 Hz, 1H, H20S), 3.86 (d, J = 3.9 Hz, 1H, 2'OFi), 3.79 (d, J = 6.6 Hz, 1H, H3), 2.55 (m, 1H, H6a), 2.46 (d, J = 3.8 Hz, 1H, ~70H), 2.41 (s, 3H, 4Ac), 2.38 (m, 2H, H14), 2.23 (s, 3H, lOAc) , 1.82 (m, 1H, H6~) , 1.80 (br s, 3H, Ptel8) , 1. 74 (s, 1H, lOH), 1.68 (s, 3H, Mel9), 1.21 (s, 3H Mel7), 1.13 (s, 3H, Mel6).
F
OAc O O
OH
Ph i - Om~u %, H OH
O
Preparation of 3'-desphenyl-3'-(4-fluorophenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-1-benzoyl-3-triethylsilyloxy-4-(4-fluorophenyl)azetidin-2-one (570 mg, 1.43 mmol) in 2 mL
of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before ... ....... ....... .. t.

1 mL of a 10~ solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 315 mg of a mixture containing (2'R,3'S)-2',7-(bis)-triethylsilyl-3'-desphenyl-3'-(4-fluorophenyl) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 315 mg (0.286 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48$
aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 250 mg of material which was purified by flash chromatography to give 160 mg (64$) of 3'-desphenyl-3'-(4-fluorophenyl) taxol, which was recrystallized from methanol/water.
m, p. 171-173 °C; [a]25Na-49.0° (c 0.005, CHC13).
1H NMR (CDC13, 300 MHz) 6 8.13 (d, J = 7.5 Hz, 2fi, benzoate ortho), 7.25 (m, 2H, aromatic), 7.61 (m, 1H, aromatic), 7.50 (m, 4H, aromatic), 7.43 (m, 2H, aromatic), 7.10 (m, 2H, aromatic),-6.96 (d, J = 8.7 Hz, 1H, NH), 6.27 (s, 1H, H10), 6.25 (dd, J = 8.7, 8.7 EIz, lii, Fil3) , 5.79 (dd, J = 8.7, 2.4 Hz, 1H, H3'), 5.67 (d, J = 7.1 Hz, 1H, H2S), 4.45 (dd, J =
7.9 Hz, 1H, H5), 4.76 (dd, J = 4.8, 2.4 Hz, 1F~, H2'), 4.39 ' ' 29 (m, 1H, Ii7) , 4.31 (d, J = 8. 9 Hz, 1H, H20a) , 4 . 20 (d, J = 8.9 Hz, 1H, H20S), 3.80 (d, J = 7.1 Hz, 1H, H3), 3.57 (d, J = 4.8 Hz, 1H, 2'OH) , 2. 58 (m, 1H, H6a) , 2. 43 (d, J = 4 . 3 Hz, 1H, 70H), 2.38 (s, 3H, 4Ac), 2.30 (m, 2H, H14), 2.24 (s, 3H, lOAc), 1.85 (m, 1H, H6S), 1.80 (br s, 3H, Mel8), 1.69 (s, 1H, lOH), 1.55 (s, 3H, Mel9), 1.23 (s, 3H, Mel7), 1.14 (s, 3H, Mel6).

EXAMPLE:10_ O Ac O Ph 7 ~ O
~~ OH
~Onnui ,' '' H OH _ _ Ph~O
Ac O
O
Preparation of N-debenzoyl-N-(4-chlorobenzoyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of (+)-cis-1-(9-chlorobenzoyl)-3-triethylsilyloxy-4-phenylazetidin-2-one (215 mg, 0.515 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 2 h before 1 mL of a 10~ solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 320 mg of crude (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-(9-chlorobenzoyl) taxol.
To a solution of 320 mg (0.286 mmol) of this crude product in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48~ aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate.
Evaporation of the ethyl acetate solution gave 252 mg of material which was purified by flash chromatography to give 213 mg (89~) of N-debenzoyl-N-(4-chlorobenzoyl) taxol, which was recrystallized from methanol/water.

:n.p. 179-181 'C; [a)ZSya -49.8° (c 0.01, CHC13) .
-H ::NiR (CDC13, 300 MHz) 8 8.12 (d, J = 7.1 Hz, 2H, benzoate ortho), 7.69 (m, 2H, aromatic), 7.60 (m, 1H, aromatic), 7.49 (m, 9H, aromatic) , 7 .03 (d, J = 8.8 Hz, 1H, NH) , 6. 26 (s, 1H, H10) , 6. 21 (dd, J = 8 .2, 8 .2 Hz, 1H, H13) , 5 . 76 (dd, J = 8 . 8, 2 . 2 Hz, 1H, H3' ) , 5 . 66 (d, J = 7 . 1 Hz, 1H, H2p) , 4 . 92 (dd, J =
9 . 9, 1 . 1 Hz, 1H, H5) , 4 . 77 (dd, J = 5 . 5, 2 .2 Hz, 1H, H2' ) , 9 . 38 (m, 1H, H7 ) , 4 . 29 (d, J = 8 . 8 Hz, 1H, H20a) , 4 . 18 (d, J = 8 . 5 Hz, 1H, H20~) , 3 .78 (d, J = 6. 6 Hz, 1H, H3) , 3. 35 (d, J = 5. 5 Hz, 1H, 2'OH), 2.55 (m, 1H, H6a), 2.99 (d, J = 4.2 Hz, 1H, 70H), 2.36 (s, 3H, 9Ac), 2.28 (m, 2H, H14), 2.22 (s, 3H, lOAc), 1 . 85 (m, 1H, H6~3) , 1 .77 (br s, 3H, MelB) , 1 .76 (s, 1H, lOH) , 1.67 (s, 3H, Mel9), 1.22 (s, 3H, Mel7), 1.13 (s, 3H, Mel6).

E_YAMP_LE 11 O Ac O Ph O O
~ / OH
/ N~ ~Omun I ~o H OH _ Br Hp O
Ph \' AcO
O
Preparatoion of N-debenzoyl-N-(9-bromobenzoyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.285 mmol) in 2 mL of THF at -45 °C was added dropwise 0.175 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 ~C, a solution of (+) -cis-1- (4-bromobenzoyl) -3-triethylsilyloxy-4-phenylazetidin-2-one (236 mg, 0.513 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 2 h before 1 :nI. of a 10~ solution of AcOH in THF was added. The mixture :,ras partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 322 mg of crude (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-(4-bromobenzoyi) taxol.
To a solution of 322 mg of this crude product in 12 mL of acetonitrile and 0.6 mL of pyridine at 0 °C was added 1.8 mL or ~3~ aqueous HF. The mixture was stirred at 0 °C for 3 h, then aL 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 312.2 mg of material which was purified by flash chromatography to give 254 mg (96~) of N-debenzoyl-N-(4-bromobenzoyl) taxol, which was recrystallized from methanol/water.

m. p. 182.5-185 °C; [a]25 -47.8° (c 0.0051, CHC13).
Na 1H NMR (CDC13, 300 MHz) 8 8.14 (d, J = 7.1 Hz, 2H, benzoate ortho), 7.7-7.3 (m, 12H, aromatic), 6.96 (d, J = 8.8 Hz, 1H, NH), 6.27 (s, 1H, H10), 6.22 (dd, J = 9.1, 9.1 Hz, 1H, H13), 5.77 (dd, J = 8.8, 2.2 Hz, 1H, H3'), 5.67 (d, J = 7.2 Hz, 1H, H2S), 4.94 (dd, J = 9.9, 2.2 Hz, 1H, H5), 4.78 (dd, J =
5.0, 2.7 Hz, 1H, H2'), 4.40 (m, 1H, H7), 4.30 (d, J = 8.5 Hz,lH, H20a), 4.19 (d, J = 8.5 Hz, 1H, H20S), 3.79 (d, J = 7.2 Hz, 1H, H3), 3.98 (d, J = 5.0 Hz, 1H, 2'OH), 2.54 (m, 1H, H6a), 2.45 (d, J = 4.4 Hz, 1H, 70H), 2.37 (s, 3H, 4Ac), 2.30 (m, 2H, Hl4a, H14S) , 2.24 (s, 3H, lOAc) , 1.88 (m, lii, H6p) , 1.78 (br s, 3H, Mel8), 1.68 (s, 3H, Mel9), 1.24 (s, 3H, Mel7), 1. 14 (s, 3H, Mel6 ) .

OAc O Ph O
- ~~ ~ off I ~N ~ o.......
i ,,,,,,,,, H OH _ O
Ph \' Ac0 O
Preparation of N-debenzoyl-N-(4-methylbenzoyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.285 mmol) in 2 mL of THF at -45 °C was added dropwise 0.175 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 ~C, a solution of (+)-cis-1-(4-methylbenzoyl)-3-triethylsilyloxy-4-phenylazetidin-2-one (203 mg, 0.513 mmol) in 2 mL of THF was added dropwise to the mixture. The solution ~.aas warmed to 0 °C and kept at that temperature for 2 h betore 1 mL of a 10~ solution of AcOH in THF was added. The mixture ~.~as partitioned between saturated aqueous NaHC03 and 60/40 et'~yl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 386 mg of crude (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-(4-methylbenzoyl) taxol.
To a solution of 386 mg of this crude product in 6 mL of acetonitrile and 0.3 mL of pyridine at 0 °C was added 0.9 mL of =)8o aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 283 mg of material which was purified by flash chromatography to give 240 mg (97~) of N-debenzoyl-N-(4-methylbenzoyl) taxol, which was recrystallized from methanol/water.

m. p. 175-176.5 °C; [a]25Na-50.9° (c 0.00975, CHC13).
1H NMR (CDC13, 300 MHz) 6 8.13 (d, J = 7.1 Hz, 2H, benzoate ortho), 7.7-7.3 (m, lOH, aromatic), 7.19 (d, J = 7.7 Hz, 2H, benzoate meta), 6.94 (d, J = 8.8 Hz, 1H, NH), 6.27 (s, 1H, H10), 6.22 (dd, J = 9.3, 9.3 Hz, 1H, H13), 5.77 (dd, J = 9.3, 2.8 Hz, 1H, H3'), 5.67 (d, J = 7.2 Hz, 1H, H2S), 4.94 (dd, J = 9.9, 2.2 Hz, 1H, H5), 4.78 (dd, J = 4.9, 2.8 Hz, 1H, H2' ) , 4 .42 (m, 1H, H7) , 4.30 (d, J = 8.5 Hz, lEi, Fi20a) , 9 . 19 (d, J = 8. 5 Hz, lEi, H20 f3) , 3.79 (d, J = 7. 2 EEz, 10 1H, H3), 3.60 (d, J = 4.9 Hz, 1H, 2'OH), 2.53 (m, 1H, H6a), 2. 46 (d, J = 4.4 Hz, 1H, 70Ei) , 2. 38 (s, 3H, 4Ac) , 2. 37 (s, 3H, ArMe) , 2. 31 (m, 2H, Hl4a, H14 S) , 2. 23 (s, 3H, lOAc) , 1.87 (m, 1H H6 ~) , 1. 78 (br s, 3H, Mel8) , 1.68 (s, 3H, Mel9) , 1.23 (s, 3H, Mel7), 1.14 (s, 3H, Mel6).

OAc O Ph O O
OH
N _ O~liiii~
H OH
(CH3 ) 3C
HO
p H s O
Ac0 Ph O

Preparation of N-debenzoyl-N-(4-t-butylbenzoyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of (+)-cis-1-(9-t-butylbenzoyl)-3-triethylsilyloxy-4-phenylazetidin-2-one (226 mg, 0.515 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 2 h before 1 mL of a 10~ solution of AcOH in THF was added.
The mixture was partitioned between saturated aqueous rdafIC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 330 mg of crude (2'R,3'S)-2',7-(bis)-triethylsilyl-N-debenzoyl-N-(4-t-butylbenzoyl) taxol.
To a solution of 330 mg (0.289 mmol) of this crude product in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48$ aqueous FIF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and 2U partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation. of the ethyl acetate solution gave 260 mg of material which was purified by flash chromatography to give 240 mg (92$) of N-debenzoyl-N-(4-t-butylbenzoyl) taxol, which was recrystallized from methanol/-water.

m. p. 171-173 °C; [a]25Na-49.1° (c 0.05, CHC13).
1H NMR (CDC13, 300 MHz) 6 8.13 (d, J = 7.1 Hz, 2H, benzoate ortho), 7.76-7.25 (m, 12H, aromatic), 6.98 (d, J = 8.8 Hz, 1H, NH), 6.27 (s, 1H, H10), 6.21 (dd, J = 8.8, 8.8 Hz, 1H, H13), 5.77 (dd, J = 8.8, 2.7 1H, H3' ), 5.67 (d, J =
Hz, 6.6 Hz, 1H, H2~), 4.94 (dd, = 9.3, 1.2 Hz, 1H, H5), 4.78 (dd, J

J = 4.4, 2.7 Hz, 1H, H2') , 4.38 (m, 1H, H7), 4.29 (d, J
=

8.2 Fiz, 1H, H20a) , 4.20 (d, J = 8.2 Hz, lFi, H20S) , 3.79 (d, J = 6.6 Hz, 1H, H3), 3.65 (d, J = 4.4 Hz, 1H, 2'OH), 2.57 (m, 1H, H6a), 2.48 (d, J = 4.1 Hz, 1H, 70H), 2.37 (s, 3H, 4Ac) , 2.31 (m, 2Fi, H14) , 2.22 (s, 3H, lOAc) , 1.85 (m, 1H, H6S), 1.79 (br s, 3H, Mel8), 1.68 (s, 1H, lOH), 1.68 (s, 3H, Mel9), 1.29 (s, 9H, ArtBu), 1.23 (s, 3H, Mel7), 1.13 (s, 3H, Mel6).

OAc O Ph O
OH
/ N~/~~_ Onnui I I =-_ w J H OH

/O
Ph~~ Ac0 \\O
Preparation of N-debenzoyl-N-(4-methoxybenzoyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.285 mmol) in 2 mL of THF at -95 °C was added dropwise 0.175 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of (+)-cis-1-(4-methoxybenzoyl)-3-triethylsilyloxy-9-phenylazetidin-2-one (211 mg, 0.513 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 2 h before 1 mL of a 10~ solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 406 mg of crude (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-(9-methoxybenzoyl) taxol.
To a solution of 406 mg (0.112 mmol) of this crude product in 12 mL of acetonitrile and 0.6 mL of pyridine at 0 =C was added 1.8 mL of 98$ aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate.
Evaporation of the ethyl acetate solution gave 308 mg of material which was purified by flash chromatography to give 236 mg (99~) of N-debenzoyl-N-(4-methoxybenzoyl) taxol, which was recrystallized from methanol/water.

p. 174.5-176 °C; [a]z5~d -49.5° (c 0.0084, CHC13) .
-:i CJMR (CDC13, 300 MHz) b 8.13 (d, J = 7.1 Hz, 2H, benzoate ~rth:~) , 7 .75-7 .3 (m, lOH, aromatic) , 6. 90 (d, J =8.2 Hz, 1H, CJH), 6.88 (d, J = 7.1 Hz, 2H, benzoate meta), 6.27 (s, 1H, H10), 6.22 (dd, J = 8.8, 8.8 Hz, 1H, H13), 5.76 (dd, J = 8.8, 2.7 Hz, 1H, H3'), 5.67 (d, J = 7.1 Hz, 1H, H2), 4.94 (dd, J =
9. 9, 2 . 2 Hz, 1H, H5) , 4 . 78 (d, J = 2 .7 Hz, 1H, H2' ) , 4 . 40 (dd, J = 11.0, 7.1 Hz, 1H, H7), 9.30 (d, J = 8.5 Hz, 1H, H20a), 4.19 (d, J = 8.5 Hz, 1H, H20~3), 3.82 (s, 3H, OMe), 3.79 (d, J =
7 . 1 Hz, 1H, H3) , 2 . 55 (m, 1H, H6a) , 2 .38 (s, 3H, 4Ac) , 2 .30 (m, 2Ei, Hl4a, fil4(~) , 2 . 23 (s, 3H, lOAc) , 1 .87 (m, 1H, H6(3) , 1 . 78 (br s, 3H, MelB) , 1 . 68 (s, 3H, Mel9) , 1 .23 (s, 3H, Mel7) , 1 . 14 (s, 3H, Mel6) .

E
O Ac O
-\ _ 1 ~ OH
F ~ =
HO H
O
Ph " Ac0 O
Preparation of N-debenzoyl-N-(9-fluorobenzoyl)-3'-desphenyl-3'-(4-fluorophenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.179 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-1-(4-fluorobenzoyl)-3-triethylsilyloxy-9-(4-fluorophenyl)azetidin-2-one (600 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10~ solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/90 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 315 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-(4-fluorobenzoyl)-3'-desphenyl-3'-(4-fluorophenyl) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 315 mg (0.282 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48~ aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C
for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 250 mg of material which was purified by flash chromatography to give 160 mg (63~) of N-debenzoyl-N-(4-fluorobenzoyl)-3'-desphenyl-3'-(4-fluorophenyl) taxol, which was recrystallized from methanol/water.
m.p. 177-179 °C; [ocJzs,,a -48.8° (c 0.003, CHC13) .
=H NMR (CDC13, 300 MHz) b 8.11 (d, J = 7.1 Hz, 2H, benzoate ortho>, 7.76 (d, J = 8.7 Hz, 2H, benzamide ortho), 7.73 (m, 2H, aromatic), 7.61 (m, 1H, aromatic), 7.48 (m, 6H, aromatic),. 7.06 (m, 2H, aromatic), 7.02 (d, J = 8.8 Hz, 1H, NH), 6.26 (s, 1H, H10), 6.22 (dd, J = 8.8, 8.8 Hz, 1H, H13), 5.74 (dd, J = 8.8, 2 . 2 Hz, 1H, H3' ) , 5 . 66 (d, J = 7 . 1 Hz, 1H, H2(~) , 4 . 93 (dd, J =
9 . 3, 1 . 1 Hz, 1H, H5) , 9 . 74 (dd, J = 5 .0, 2 .2 Hz, 1H, H2' ) , 9 . 36 (m, 1H, H7 ) , 4 . 29 (d, J = 8 . 8 Hz, 1H, H200c) , 4 . 18 (d, J = $ . 8 Hz, 1H, H20p) , 3 . 77 (d, J = 7 . 1 Hz, 1H, H3) , 3 .70 (d, J = 5 . 0 Hz, 1H, 2' OH) , 2 . 77 (m, 1H, H6oc) , 2 . 52 (d, J = 4 . 4 Hz, lFi, 70H), 2.36 (s, 3H, 4Ac), 2.30 (m, 2H, H14), 2.22 (s, 3H, lOAc), 1.86 (m, 1H, H6p), 1.78 (br S, 3H, MelB), 1.77 (s, 1H, lOH), 1 . 67 (s, 3H, Mel9) , 1 .21 (s, 3H, Mel7) , 1 . 13 (s, 3H, Mel6) .

O Ac O Ph O O
1 \ ~ - i pH
,, L i ,,",, H OH _ F HO O H ~~~
Ph \\ AcO
O
Preparation of N-debenzoyl-N-(4-fluoroobenzoyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol)) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -95 °C, a solution of (+)-cps-1-(4-fluorobenzoyl)-3-triethylsilyloxy-4-phenylazetidin-2-one (225 mg, 0.515 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 2 h before 1 mL of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/90 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 325 mg of crude (2'R,3'S)-2',7-(bis)triethylsilyl- N-debenzoyl-N-(9-fluorobenzoyl) taxol.
To a solution of 325 mg (0.286 mmol) of this crude product in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48% aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate.
Evaporation of the ethyl acetate solution gave 260 mg of material which was purified by flash chromatography to give 240 mg (92%) of N-debenzoyl-N-(4-fluorobenzoyl) taxol, which was recrystallized from methanol/water.

m.p. 175-177 'C; (a]ZS,,a -51.2° (c 0.01, CHC13) .
-H tIMR (CDC13, 300 MHz) 8 8.13 (d, J = 7.1 Hz, 2fi, benzoate ortho), 7.74 (m, 2H, aromatic), 7.62 (m, 2H, aromatic), 7.46 (m, 6fi, aromatic) , 7 . 06 (m, 2H, aromatic) , 6. 95 (d, J = 8 . 8 Hz, 1H, NH) , 6.28 (s, 1H, H10) , 6.22 (dd, J = 8.2, 8 .2 Hz, 1H, H13), 5.76 (dd, J = 8.8, 2.8 Hz, 1H, H3'), 5.67 (d, J = 7.1 Hz, 1H, H2~3) , 4 . 93 (dd, J = 9. 9, 2 . 2 Hz, 1H, H5) , 4 . 78 (dd, J =
5.5, 2.8 Hz, 1H, H2'), 4.39 (m, 1H, H7), 4.30 (d, J = 8.8 Hz, 1H, H20a) , 4 . 22 (d, J = 8 .8 Hz, 1H, H20(~) , 3 . 79 (d, J = 7 . 1 Hz, lfi, H3) , 3 . 54 (d, J = 5 .5 Hz, lfi, 2'OH) , 2.54 (m, 1H, H6a) , 2.46 (d, J = 4.4 Hz, 1H, 7pH), 2.37 (s, 3H, 4Ac), 2.30 (m, 2H, H14 ) , 2 .26 (s, 3H, lOAc) , 1 .87 (m, 1H, H6~3) , 1 .79 (br s, 3H, Mel8) , 1 . 79 (s, 1H, lOH) , 1 . 67 (s, 3H, Mel9) , 1 .24 (s, 3H, Mel7) , 1 . 12 (s, 3Ei, Mel6) .

/ OAc O \ ~ O
Ofi ~N _ Olnmll H OEi Preparation of N-debenzoyl-N-(4-methylbenzoyl)-3'-desphenyl-3'-(4-chlorophenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.285 mmol) in 2 mL of THF at -45 °C was added dropwise 0.175 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-1-(4-methylbenzoyl)-3-triethyl-silyloxy-4-(4-chlorophenyl)azetidin-2-one (718 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10~ solution of AcOH in THF was added.
The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic Ph O

layer gave a residue which was purified by filtration through silica gel to give 329 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-rJ-debenzoyl-N-(4-methylbenzoyl)-3'-desphenyl-3'-(4-chlorophenyl) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 329 mg of the mixture obtained from the previous reaction in 12 mL of acetonitrile and 0.6 mL of pyridine at 0 °C was added 1.8 mL of 48~ aqueous HF.
The mixture was stirred at 0 °C for 3 h, then at 25 °C for 10 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 376 mg of material which was purified by flash chromatography to give 175 mg (68~) of N-debenzoyl-N-(4-methylbenzoyl)-3'-desphenyl-3'-(4-chlorophenyl) taxol, which was recrystallized from methanol/water.
m. p. 167.5-171 °C; [a]25Na-53.7° (c 0.01105, CHC13).
1H NMR (CDC13, 300 MHz) d 8.12 (d, J = 8.2 Hz, 2H, benzoate ortho), 7.65-7.3 (m, 9H, aromatic), 7.19 (d, J = 8.2 Hz, 2H, benzoate meta), 6.97 (d, J = 8.8 Hz, 1H, NH), 6.27 (s, 1H, 20 H10), 6.22 (dd, J = 9.9, 9.9 Hz, 1H, H13), 5.76 (dd, ,7 = 8.8, 2.2 Hz, 1H, H3'), 5.67 (d, J = 7.1 Hz, 1H H2s), 4.94 (dd, J = 9.9, 2.2 Hz, 1H, H5), 4.76 (dd, J = 4.4, 2.2 Hz, 1H, H2'), 4.39 (m,:lH, H7), 4.30 (d, J = 8.8 Hz, lli, H20a), 4.19 (d, J = 8.8 Hz, 1H, H20S) , 3.79 (d, J = 7.1 Hz, 1H, H3) , 3.75 (d, J = 4.4 Hz, 1H, 2'OH), 2.54 (m, 1H, H6a), 2.49 (d, J = 4.4 Hz, 1H, 70H), 2.38 (s, 3H, 4Ac), 2.37 (s, 3H, ArMe), 2.31 (m, 2H, Hl4a, H14S), 2.23 (s, 3H, lOAc), 1.87 (m, 1H, H6a), 1.80 (br s, 3H, Mel8), 1.68 (s, 3H, Mel9), 1.22 (s, 3H, Mel7), 1.13 (s, 3H, Mel6).

EXAMPLE 1~
F
UAC
O ~ O
ii~y El ort C 1 HO F~
O
Ph \' 11c0=

Preparation of N-debenzoyl-N-(4-chlorobenzoyl)-3'-desphenyl-3'-(4-fluorophenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 ~C, a solution of cis-1-(4-chlorobenzoyl)-3-triethylsilyloxy-4-(4-fluorophenyl)azetidin-2-one (630 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10~ solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 330 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-(4-chlorobenzoyl)-3'-desphenyl-3'-(4-fluorophenyl) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 330 mg (0.283 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48~ aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C
for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 250 mg of material which was purified by flash chromatography to give 166 mg (65~) of N-debenzoyl-N-(4-':~lorobenzoyl)-3'-desphenyl-3'-(4-fluorophenyl) taxol, which :ras re~~ystallized from methanol/water.
m.p. 17.g-179 °C; [a)~S,,a -51.9° (c 0.01, CHC13) .
-H NMR (CDC13, 300 MHz) b 8.13 (d, J = 7.1 Hz, 2H, benzoate ortho), 7.64 (m, 3H, aromatic), 7.49 (m, 4H, aromatic), 7.36 (m, 2H, aromatic) , 7 , 10 (m, 2H, aromatic) , 6. 97 (d, J = 8 . 8 Eiz, 1H, NH) , 6 . 27 (s, 1H, H10) , 6.21 (dd, J = 8.8, 8 .8 Hz, 1E~, Eil3 ) , 5 . 7 6 (dd, J = 8 . 8, 2 . 2 Hz, lfi, H3' ) , 5 . 6'7 (d, J = 7 . 2 Hz, lii, H2~3) , 4 . 94 (dd, J = 9. 3, 2 .2 Hz, 1H, H5) , 4 . 75 (dd, J =
4 . 4, 2 .2 Hz, 1H, Ei2' ) , 4 .39 (ddd, J = 11 .0, 6 . 6, 3 . 9 Hz, 1H, H7), 4.30 (d, J = 8.8 Hz, 1H, H20a), 4.19 (d, J = 8.8 Hz, 1H, H20(3) , 3 . 79 (d, J = 7 .2 Hz, 1H, H3) , 3. 60 (d, J = 4 . 4 Hz, 1H, 2'OH), 2.54 (m, 1H, H6a), 2.47 (d, J = 3.9 Hz, 1H, 70H), 2.38 (s, 3H, 4Ac) , 2 .30 (m, 2H, H14) , 2 .28 (s, 3H, lOAc) , 1 .87 (m, 1H, H6(3) , 1 . 78 (br s, 3H, MelB) , 1 .78 (s, 1H, lOH) , 1 . 68 (s, 3H, Mel9), 1.23 (s, 3H, Mel7), 1.14 (s, 3H, Mel6).

EXAMPLE 1~
F
O OAc O
no ~o EE OEi _ B r Fi0 Ph~o Ac O
O
Preparation of N-debenzoyl-N-(4-bromobenzoyl)-3'-desphenyl-3'-(4-fluorophenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.285 mmol) in 2 mL of THF at -45 °C was added dropwise 0.087 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-1-(4-bromobenzoyl)-3-triethylsilyloxy-4-(4-fluorophenyl)azetidin-2-one (689 mg, 1.93 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10~s solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 433 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-(4-bromobenzoyl)-3'-desphenyl-3'-(4-fluorophenyl) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 433 mg of the mixture obtained from the previous reaction in 12 mL of acetonitrile and 0.6 mL of pyridine at 0 °C was added 1.8 mL of 98~ aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 317 mg of material which was purified by flash chromatography to give 187 mg (69~) of N-debenzoyl-N-(4-bromobenzoyl)-3'-desphenyl-3'-(4-fluorophenyl) taxol, which was recrystallized =om methanol/water.
m.p. 174.5-175.5 ~C; [a]ZSVa-46.9° (c 0.00735, CHC13) .
-H ~IMR (CDC13, 300 MHz) 8 8.13 (d, J = 7.2 Hz, 2H, benzoate ortho), 7.7-7.4 (m, 9H, aromatic), 7.10 (dd, J = 8.3, 8.3 Hz, 2H, aromatic), 6.97 (d, J = 8.8 Hz, 1H, NH), 6.27 (s, 1H, H10), 5.23 (dd, J = 8.8, 8.8 Hz, 1H, H13), 5.76 (dd, J = 8.8, 2.2 Hz, 1H, H3' ) , 5 . 67 (d, J = 7 . 1 Hz, 1H, H2(3) , 4 . 94 (dd, J = 9. 9, 2 . 2 Hz, 1H, H5) , 4 . 75 (dd, J = 4 .4, 2 . 2 Hz, 1H, H2' ) , 4 . 39 (m, 1H, H7), 9.31 (d, J = 8.5 Hz, 1H, H20a), 4.19 (d, J = 8.5 Hz, 1H, H20~3) , 3 . 79 (d, J = 7 . 1 Hz, 1H, H3) , 3 . 59 (d, J = 4 . 4 Fiz, 1H, 2'OH), 2.54 (m, 1H, H6a), 2.47 (d, J = 4.4 Hz, 1H, 70H), 2.36 (s, 3H, 4Ac) , 2 .30 (m, 2H, Hl4a, H14(~) , 2 .24 (s, 3H, lOAc) , 1.88 (m, 1H, H6a), 1.78 (br s, 3H, MelB), 1.74 (s, lFi, lOH), 1 . 68 (s, 3H, Mel9) , 1 .23 (s, 3H, Mel7) , 1. 14 (s, 3H, Mel6) .

E_XA_M_PLE 2 Q
F
Ac O
\ 1' ~ Ofi O
Ph~ Ac0 ~~O
Preparation of N-debenzoyl-N-(9-methylbenzoyl)-3'-desphenyl-3'-(4-fluorophenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-1-(4-methylbenzoyl)-3-triethylsilyloxy-4-(4-fluorophenyl)azetidin-2-one (592 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10~ solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 335 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-(4-methylbenzoyl)-3'-desphenyl-3'-(4-fluorophenyl) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 335 mg (0.30 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48~ aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C
for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 280 mg of material which was purified by flash chromatography to give 163 mg (64~) of N-debenzoyl-N-(4-_, :r.ethylbenzoyl)-3'-desphenyl-3'-(4-fluorophenyl) taxol, which :cas =ecrystallized from methanol/water.
m.p. 172-173 °C; [a)z5"a -52.0° (c 0.01, CHC13) .
-H iIMR (CDC13, 300 MHz) S 8.13 (d, J = 7.1 Hz, 2H, benzoate ortho), 7.61 (m, 3H, aromatic), 7.48 (m, 4H, aromatic), 7.18 (m, 2H, aromatic), 7.10 (m, 2H, aromatic), 6.95 (d, J = 8.8 Hz, 1H, rdH) , 6.27 (s, 1H, H10) , 6.21 (dd, J = 8. 8, 8. 8 Hz, 1H, j-i13 ) , 5 . 77 (dd, J = 8 . 8, 2 . 2 Hz, 1H, H3' ) , 5 . 67 (d, J = 7 . 2 Hz, 1H, H2~3) , 4 . 94 (dd, J = 9.3, 1 .7 Hz, 1H, H5) , 4 .75 (dd, J =
4.4, 2.2 Hz, 1H, H2'), 4.39 (ddd, J = 11.0, 6.6, 4.4 Hz, 1H, H7), 4.30 (d, J = 8.8 Hz, 1H, H20a), 4.19 (d, J = 8.8 Hz, 1H, H20~3), 3.79 (d, J = 7.2 Hz, 1H, H3), 3.67 (d, J = 4.4 Hz, 1H, 2'OH), 2.54 (ddd, J = 9.3, 14.8, 6.6 Hz, 1H, H6a), 2.46 (d, J =
4.4 Hz, 1H, 70H), 2.37 (s, 3H, 4Ac), 2.36 (s, 3H, Ark,), 2.30 (m, 2H, H14), 2.23 (s, 3H, lOAc), 1.87 (ddd, J = 11.0, 14.8, 1.7 Hz, 1H, H6(~), 1.79 (br s, 3H, MelB), 1.79 (s, 1H, lOH), 1.68 (s, 3H, Mel9), 1.22 (s, 3H, Mel7), 1.14 (s, 3H, Mel6).

OC Ha i F
~~ Ac0 O
Preparation of N-debenzoyl-N-(4-fluorobenzoyl)-3'-desphenyl-3'-(4-methoxyphenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 'C, a solution of cis-1-(4-fluorobenzoyl)-3-triethylsilyloxy-4-(4-methoxyphenyl)azetidin-2-one (610 mg, 1.43 mmol) in 2 mL of TE~F was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/90 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 330 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-(4-fluorobenzoyl)-3'-desphenyl-3'-(4-methoxyphenyl) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 330 mg (0.292 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48% aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C
for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 260 mg of material which was purified by flash chromatography to give 155 mg (60%) of N-debenzoyl-N-(4-luorobenzoyl)-3'-desphenyl-3'-(4-methoxyphenyl) taxol, which -.gas recrystallized from methanol/water.
m. o . 169-170 °C: [a) 25,,a -50 . 9° (c 0 .01, CHC13) .
-H NMR (CDC13, 300 MHz) 8 8.14 (d, J = 7.1 Hz, 2H, benzoate ortho), 7.57 (m, 7H, aromatic), 7.06 (m, 2H, aromatic), 6.94 (m, 2H, aromatic) , 6 . 85 (d, J = 8 . 8 Hz, 1H, NH) , 6. 27 (s, lEi, H10), 6.20 (dd, J = 8.8, 8.8 Hz, 1H, H13), 5.72 (dd, J = 8.8, 2 . 8 Hz, 1H, H3' ) , 5 . 67 (d, J = 7 . 2 Hz, 1H, H2(~) , 4 . 99 (dd, ,J =
9. 3, 2 . 1 Hz, lEi, H5) , 9 .74 (dd, J = 4 . 9, 2 .8 Hz, 1H, fit' ) , 4 . 40 (ddd, J = 11.0, 6.6, 3.9 Hz, 1H, H7), 4.31 (d, J = 8.8 Hz, 1H, H20a) , 4 . 19 (d, J = 8 . 8 Hz, 1H, H20~3) , 3 . 80 (d, J = 7 . 2 Hz, 1H, H3) , 3 . 79 (s, 3H, ArQ,~) , 3 .51 (d, J = 9 . 9 Hz, 1H, 2'OFi) , 2 . S4 (m, 1H, H6a), 2.50 (d, J = 3.9 Hz, 1H, 70H), 2.37 (s, 3H, 4Ac), 2 . 31 (m, 2H, H14) , 2 . 24 (s, 3H, lOAc) , 1 . 87 (m, 1H, H6p) , 1 . 79 (br s, 3H, MelB), 1.79 (s, 1H, lOH), 1.68 (s, 3H, Mel9), 1.24 (s, 3H, Mel7) , 1 . 14 (s, 3H, Mel6) .

AMA
OC i i, O
O
w -H OH _ Ph~O
Ac O
O
Preparation of N-debenzoyl-N-(4-methylbenzoyl)-3'-desphenyl-3'-(4-methoxyphenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-1-(4-methylbenzoyl)-3-triethylsilyloxy-4-(4-methoxyphenyl)azetidin-2-one (610 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10~ solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 325 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-(4-methylbenzoyl)-3'-desphenyl-3'-(9-methoxyphenyl) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 325 mg (0.289 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48~ aqueous HE. The mixture was stirred at 0 °C for 3 h, then at 25 °C
for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 265 mg of material which was purified by flash chromatography to give 165 mg (64~) of N-debenzoyl-N-(4-:~ethylbenzoyl)-3'-desphenyl-3'-(4-methoxyphenyl) taxol, :~hich :aas recrystallized from methanol/water.
m. p . 173-174 °C: [a] zSVa -50 . 2° (c 0 . O1, CHCl~) .
-H NMR (CDC13, 300 MHz) S 8.13 (d, J = 7.1 Hz, 2H, benzoate ortho), 7.61 (m, 3H, aromatic), 7.51 (m, 2H, aromatic), 7.40 (m, 2H, aromatic), 7.19 (m, 2H, aromatic), 6.93 (m, 2H, aromatic) , 6.86 (d, J = 8.8 Hz, 1H, NH) , 6.27 (s, 1H, H10) , 6.21 (dd, J = 8.8, 8.8 Hz, 1H, H13), 5.70 (dd, J = 8.8, 2.8 Hz, 1H, H3' ) , 5 . 66 (d, J = 7 . 2 Hz, 1H, H2p) , 4 . 94 (dd, J = 9 , 9, 2 . 2 Hz, lEi, H5) , 4 . 74 (dd, J-= 5 .5, 2 . 8 Hz, 1H, H2' ) , 4 . 40 (ddd, J
- 11.0, 6.5, 3.8 Hz, 1H, H7), 4.30 (d, J = 8.8 Hz, 1H, Ei20a), 4 . 19 (d, J = 8. 8 Hz, 1H, H20~3) , 3. 79 (d, J = 7 . 2 Hz, 1H, H3) , 3.78 (s, 3H, ArQ~) , 3. 63 (d, J = 5.5 Hz, 1H, 2'OFi) , 2 . 59 (m, 1H, H6a), 2:46 (d, J = 3.8 Hz, 1H, 70H), 2.38 (s, 3H, Ark), 2.37 (s, 3H, 4Ac), 2.31 (m, 2H, H14), 2.23 (s, 3H, lOAc), 1.88 (m, 1H, H6(3), 1.80 (br s, 3H, MelB), 1.80 (s, 1H, lOH), 1.68 (s, 3H, Mel9) , 1 .23 (s, 3H, Mel7) , 1 . 14 (s, 3H, Mel6) .

OAc O
- / OH
ni "~o~,,~
HO
Ph~ Ac01 \'O
Preparation of N-debenzoyl-N-(4-fluorobenzoyl)-3'-desphenyl-3'-(4-chlorophenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol)) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-1-(4-fluorobenzoyl)-3-triethylsilyloxy-9-(4-chlorophenyl)azetidin-2-one (620 mg, 1.93 mmol) in 2 mL of TfiF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 325 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-(4-fluorobenzoyl)-3'-desphenyl-3'-(4-chlorophenyl) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 325 mg (0.286 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 98% aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C
for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 260 mg of material which was purified by flash chromatography to give 161 mg (62%) of N-debenzoyl-N-(4-fluorobenzoyl)-3'-desphenyl-3'-(4-chlorophenyl) taxol, which :gas recrystallized from methanol/water.
m.p. 172-174 °C; [OC]ZSVa -56.0° (c 0.01, CHC13) .
-H flhiR (CDC13, 300 MHz) 8 8.12 (d, J = 7.1 Hz, 2H, benzoate ortho), 7.73 (m, 2H, aromatic), 7.60 (m, 1H, aromatic),7.50 (m, 2H, aromatic), 7.38 (m, 9H, aromatic), 7.06 (m, 2H, aromatic), 7 .05 (d, J = 8 . 8 Hz, 1H, NH) , 6. 27 (s, 1H, H10) , 6. 22 (dd, J =
7.7, 7.7 Hz, 1H, H13), 5.75 (dd, J = 8.8, 2.8 Hz, 1H, H3'), 5.65 (d, J = 7.1 Hz, 1H, H2~3), 4.92 (dd, J = 9.3, 1.6 Hz, 1H, H5), 4.75 (dd, J = 4.9, 2.8 Hz, 1H, H2'), 4.41 (m, 1H, H7), 4 .29 (d, J = 8 . 2 Hz, 1H, H200c) , 4 . 17 (d, J = 8 .2 Hz, 1H, H20(3) , 3 . 84 (d, J = 4 . 4 Hz, 1H, 2'OH) , 3 .78 (d, J = 7 . 1 Eiz, 1H, H3), 2.55 (d, J = 4.4 Hz, 1H, 70H), 2.52 (m, 1H, H6a), 2.36 (s, 3H, 9Ac), 2.29 (m, 2H, H14), 2.21 (s, 3H, lOAc), 1.86 (m, 1H, H6(3) , 1 .79 (br s, 3H, MelB) , 1 .78 (s, 1H, lOH) , 1 . 67 (s, 3H, Mel9) , 1 . 29 (s, 3H, Mel7) , 1 . 12 (s, 3H, Mel6) .

OAc / O
C 1 HO l..j O
ph " Ac0 O
Preparation of N-debenzoyl-N-(4-chlorobenzoyl)-3'-desphenyl-3'-(4-chlorophenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nHuLi in hexane. After 0.5 h at -45 °C, a solution of cis-1-(4-chlorobenzoyl)-3-triethylsilyloxy-4-(4-chlorophenyl)azetidin-2-one (640 mg, 1.43 mmol) in 2 mL of TEIF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 335 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-(4-chloroobenzoyl)-3'-desphenyl-3'-(4-chlorophenyl) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 335 mg (0.291 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 98% aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C
for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 270 mg of material which was purified by flash chromatography to give 158 mg (60%) of N-debenzoyl-N-(4-chlorobenzoyl)-3'-desphenyl-3'-(4-chlorophenyl) taxol, which gas ~ecrystallized from methanol/water.
m.p. 184-185 'C: (oc]ZS,,a -52.5° (c 0.01, CHC13) .
-H NMR (CDC13, 300 MHz) 8 8.13 (d, J = 7.1 Hz, 2H, benzoate ortho) , 7 . 51 (m, 11H, aromatic) , 6. 98 (d, J = 8 . 8 Hz, 1H, NH) , 6.27 (s, 1H, H10), 6.22 (dd, J = 8.8, 8.8 Hz, 1H, H13), 5.76 (dd, J = 8 . 8, 2 . 2 Hz, 1H, H3' ) , 5 . 67 (d, J = 7 .2 Hz, 1H, H2~3) , 4.94 (dd, J = 9.9, 2.2 Hz, 1H, H5), 4.76 (dd, J = 5.0, 2.2 Hz, 1H, H2'), 4.39 (ddd, J = 10.8, 6.5, 4.4 Hz, 1H, H7), 4.30 (d, J = 8 . 8 Hz, 1H, Fi20oc) , 4 . 19 (d, J = 8 .8 Hz, lFi, H20~3) , 3 , 79 (d, J = 7 .2 Hz, 1H, H3) , 3 . 68 (d, J = 5 .0 Hz, 1H, 2'OH) , 2 . 54 (ddd, J = 9 . 9, 14 . 8, 6 . 5 Hz, 1H, H60C) , 2 . 47 (d, J = 9 . 4 Hz, 1H, 70H) , 2.37 (s, 3H, 4Ac), 2.30 (m, 2H, H14), 2.23 (s, 3H, lOAc), 1.87 (ddd, J = 10. 8, 14 .8, 2 .2 Hz, 1H, H6~3) , 1 .84 (br s, 3H, MelB) , 1 .79 (s, 1H, lOH) , 1. 68 (s, 3H, Mel9) , 1 .22 (s, 3H, Mel7) , 1 . 14 (s, 3H, Mel6) .

OAc O O
\ -II O H
Br f~0 ~ H
Ph~O
Ac O
O
Preparation of N-debenzoyl-N-(9-bromobenzoyl)-3'-desphenyl-3'-(9-chlorophenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.285 mmol) in 2 mL of THF at -45 °C was added dropwise 0.175 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cts-1-(4-bromobenzoyl)-3-triethylsilyloxy-4-(4-chlorophenyl)azetidin-2-one (359 mg, 0.715 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10~ solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 355 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-(4-bromobenzoyl)-3'-desphenyl-3'-(4-chlorophenyl) taxol and a small amount of the ( 2' S, 3' R) isomer .
To a solution of 355 mg of the mixture obtained from the previous reaction in 12 mL of acetonitrile and 0.6 mL of pyridine at 0 °C was added 1.8 mL of 48% aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 280 mg of material which was purified by flash chromatography to give 171 mg (62%) of N-debenzoyl-N-(4-bromobenzoyl)-3'-~esphenyl-3'-(4-chlorophenyl) taxol, which was recrystallized °rcm ~~ethanol/water.
m. p . 191-183 . 5 °C; [a] zs,,a -52 . 8° (c 0 .0064, CHC13) .
-H aIL~IR (CDC13, 300 MHz) $ 8.12 (d, J = 7.2 Hz, 2H, benzoate ortho), 7.65-7.3 (m, 11H, aromatic), 7.03 (d, J = 8.8 Hz, 1H, c1H) , 6.27 (s, 1H, H10) , 6.22 (dd, J = 9.3, 9. 3 Hz, 1H, H13) , 5.75 (dd, J = 8.8, 2.2 Hz, 1H, H3'), 5.66 (d, J = 7.1 Hz, 1H, H2~3), 4.93 (dd, J = 9.9, 2.2 Hz, 1H, H5), 4.75 (dd, J = 5.0, 2 . 2 Hz, 1H, H2' ) , 4 . 40 (m, 1H, H7) , 4 .30 (d, J = 8 . 5 Eiz, 1H, H20ot) , 4 . 18 (d, J = 8 .5 Hz, 1H, H20(~) , 3.77 (m, 2H, H3, 2'OH) , 2.54 (m, 1H, H6a), 2.52 (d, J = 4.4 Hz, 1H, 70H), 2.36 (s, 3H, 9Ac) , 2 .29 (m, 2H, Hl4oc, H14~) , 2.22 (s, 3H, lOAc) , 1 .87 (m, lEI, Ei6oc) , 1.79 (br s, 3H, ,MelB) , 1.73 (s, 1H, lOH) , 1 . 67 (s, 3H, Mel9), 1.21 (s, 3H, Mel7), 1.13 (s, 3H, Mel6).

OAc O
- \ _ r ~ OFi (C:ti3)3C '' HO E; , O
Ph~ Ac0 \'O
Preparation of N-debenzoyl-N-(4-t-butylbenzoyl)-3'-desphenyl-3'-(4-chlorophenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.285 mmol) in 2 mL of THF at -95 °C was added dropwise 0.175 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -95 'C, a solution of cps-1-(4-t-butylbenzoyl)-3-triethylsilyloxy-4-(4-chlorophenyl)azetidin-2-one (675 mg, 1.43 mmol) in 2 mL of TEiF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mI, of a loo solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/h exane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 317 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-(4-t-butylbenzoyl)-3'-desphenyl-3'-(9-chlorophenyl) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 317 mg of the mixture obtained from the previous reaction in 12 mL of acetonitrile and 0.6 mL of pyridine at 0 °C was added 1.8 mL of 48'b aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 354 mg of material which was purified by flash chromatography to give 186 mg (69~) of N-debenzoyl-N-(9-t-butylbenzoyl)-3'-desphenyl-3'-(4-chlorophenyl) taxol, which was recrystallized i-.gym :,~,ethanol/water.
m.p. 176.5-178 °C: (a]zSNa -51.8° (c 0.00985, CHC13) .
-H "dMR (CDC13, 300 MHz) S 8.19 (d, J = 8.8 Hz, 2H, benzoate ortho), 7.7-7.3 (m, 11H, aromatic), 6.94 (d, J = 8.8 Hz, lFi, rdH) , 6.27 (s, 1H, H10) , 6.24 (dd, J = 8 .3, 8. 3 Hz, 1H, H13) , 5.78 (dd, J = 9.3, 2.2 Hz, 1H, H3'), 5.67 (d, J = 7.1 Hz, 1H, H2(3) , 4 . 95 (dd, J = 8 .8, 1 . 1 Hz, 1H, H5) , 4 .76 (dd, J = 5.0, 2 .2 Hz, 1H, H2' ) , 4 .90 (m, 1H, H7) , 4 .31 (d, J = 8 . 5 Hz, 1H, H20a) , 4 . 20 (d, J = 8 . 5 Hz, 1H, H20(3) , 3 .80 (d, J = 7 . 1 Hz, 1H, H3), 3.64 (d, J = S.0 Hz, 1H, 2'OH), 2.55 (m, 1H, H6a), 2.46 (d, J = 9.4 Hz, 1H, 70H), 2.38 (s, 3H, 4Ac), 2.32 (m, 2H, Hl4a, H14(3) , 2 . 23 (s, 3H, lOAc) , 1 . 88 (m, 1H, H6oc) , 1 . 82 (br s, 3H, Mel8) , 1 . 77 (s, 1H, lOH) , 1 . 67 (s, 3H, Mel9) , 1 .30 (s, 9H, t-Bu) , 1 .23 (s, 3H, Mel7) , 1 . 14 (s, 3H, Mel6) .

EXAM_P_LE 2 7 F
(CH3)3C
O
Ac O
Preparation of N-debenzoyl-N-(4-t-butylbenzoyl)-3'-desphenyl-3'-(4-fluorophenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol)) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -95 °C, a solution of cis-1-(4-t-butylbenzoyl)-3-triethylsilyloxy-4-(9-fl.uorophenyl)azetidin-2-one (650 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10~ solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 330 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-(4-t-butylbenzoyl)-3'-desphenyl-3'-(9-fluorophenyl) taxol and a small amount of the (2'S,3'R) isomer.
'ro a solution of 330 mg (0.286 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 98% aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C
for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 260 mg of material which was purified by flash chromatography to give 168 mg (64%) of N-debenzoyl-N-(4-t-butylbenzoyl)-3'-desphenyl-3'-(4-fluorophenyl) taxol, which was recrystallized from methanol/water.
m.p. 180-182 °C; [aj25"a -46.3° (C 0.01, CHC13) .
'-H NMR (CDC13, 300 MHz) $ 8.12 (d, J = 7.1 Hz, 2H, benzoate ortho), 7.67 (m, 2H, aromatic), 7.60 (m, 1H, aromatic), 7.46 (m, 6H, aromatic), 7.08 (m, 2H, aromatic), 7.00 (d, J = 8.8 Hz, 1H, NH) , 6 . 27 ( s, 1H, H10) , 6. 23 (dd, J = 8 . 8, 8 . 8 Hz, 1H, H13) , 5 . 76 (dd, J = 8. 8, 2.7 Hz, lfi, H3' ) , 5. 67 (d, J = 7 . 1 Hz, 1H, H2(3) , 4 . 94 (dd, J = 9. 3, 1 . 7 Hz, 1H, H5) , 9 . 75 (dd, J =
4 . 9, 2 . 7 Hz, 1H, H2' ) , 4 .39 (m, 1H, H7) , Q .30 (d, J = 8 .2 Hz, 1H, H20a), 9.22 (d, J = 8.2 Hz, 1H, H20p), 3.78 (d, J = 7.1 Hz, 1H, H3), 3.55 (d, J = 4.9 Hz, 1H, 2'OH), 2.56 (m, 1H, H6a), 2.50 (d, J = 4.4 Hz, 1H, 70H), 2.37 (s, 3H, 4Ac), 2.30 (m, 2H, H14 ) , 2 . 22 (s, 3H, lOAc) , 1 .88 (m, 1H, Ei6(3) , 1 . 79 (br s, 3fi, MelB) , 1 . 75 (s, 1H, lOH) , 1 . 67 (s, 3H, Mel9) , 1 .29 (s, 9Fi, Artgy) , 1 .22 (s, 3H, Mel7) , 1 .13 (s, 3H, Mel6) .

EXAMPLE 2$_ F
CIi30 OAc / O
O
Ac O
Preparation of N-debenzoyl-N-(9-methoxybenzoyl)-3'-desphenyl-3'-(4-fluorophenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.285 mmol) in 2 mL of THF at -45 °C was added dropwise 0.175 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-1-(4-methoxybenzoyl)-3-triethylsilyloxy-4-(9-fluorophenyl)azetidin-2-one (619 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10~ solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 362 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-(4-methoxybenzoyl)-3'-desphenyl-3'-(4-fluorophenyl) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 362 mg of the mixture obtained from the previous reaction in 12 mL of acetonitrile and 0.6 mL of pyridine at 0 °C was added 1.8 mL of 48% aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 269 mg of material which was purified by flash chromatography to give 183 mg (71%) of N-debenzoyl-N-(4-methoxybenzoyl)-3'-desphenyl-3'-(9-fluorophenyl) taxol, which was recrystallized from methanol/water.
m.p. 172.5-174.5 °C; [oc)15~a -47.0° (c 0.0044, CHC13) .
=H NMR (CDC13, 300 MHz) $ 8.13 (d, J = 7.2 Hz, 2H, benzoate ortho), 7.7-7.4 (m, 9H, aromatic), 7.10 (dd, J = 8.8, 8.8 Hz, 2f1, aromatic) , 6.97 (d, J = 8.8 Hz, lEi, NH) , 6.27 (s, lEE, EilO) , 6.23 (dd, J = 8.8, 8.8 Hz, 1H, H13), 5.76 (dd, J = 8.8, 2.2 Hz, 1H, EE3' ) , 5 . 67 (d, J = 7 . 1 Hz, 1H, H2p) , 4 . 94 (dd, J = 9. 9, 2 . 2 Hz, 1H, H5) , 4 . 75 (dd, J = 4 . 4, 2.2 Hz, 1H, H2' ) , 9 .39 (m, 1H, H7) , 4 . 31 (d, J = 8 . 5 Hz, 1H, H20a) , 4 . 19 (d, J = 8 . 5 Hz, 1H, H20~3) , 3. 79 (d, J = 7 . 1 Hz, 1H, H3) , 3 . 59 (d, J = 4 . 9 Hz, 1H, 2'OH) , 2 . 54 (m, 1H, H6a) , 2 . 47 (d, J = 4 . 4 Eiz, 1H, 70H) , 2 . 36 (s, 3H, 4Ac) , 2 . 30 (m, 2H, Hl4a, H14(3) , 2 . 29 (s, 3H, lOAc> , 1.88 (m, 1H, H6a), 1.78 (br s, 3H, MelB), 1.74 (s, 1H, lOEi), 1 . 68 (s, 3H, Mel9) , 1 .23 (s, 3H, Mel7) , 1 . 14 (s, 3H, Mel6) .

OC H, O O
- OH
iiio, ii w H OH _ C1 Hp ' H
Ph~o \\ AcO
O
Preparation of N-debenzoyl-N-(4-chlorobenzoyl)-3'-desphenyl-3'-(4-methoxyphenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol)) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -95 °C, a solution of cis-1-(4-chlorobenzoyl)-3-triethylsilyloxy-4-(9-methoxyphenyl)azetidin-2-one (638 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 328 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-(4-chlorobenzoyl)-3'-desphenyl-3'-(4-methoxyphenyl) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 328 mg (0.286 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48% aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C
for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 270 mg of material which was purified by flash chromatography to give 170 mg (65%) of N-debenzoyl-N-(4-chlorobenzoyl)-3'-desphenyl-3'-(9-methoxyphenyl) taxol, which was recrystallized from methanol/water.
m.p. 169-171 °C; [OCJzS~a -51.1° (c 0.035, CHC13) .
~H NMR (CDC13, 300 MHz) S 8.12 (d, J = 7.1 Hz, 2H, benzoate ortho), 7.65 (d, J = 8.2 Hz, 2H, benzamide ortho), 7.51 (m, 2H, aromatic) , 7.36 (m, 5H, aromatic) , 6.91 (m, 2fi, aromatic) , 6.90 (d, J = 8 . 2 Hz, 1H, NH) , 6. 26 (s, 1H, H10) , 6.21 (dd, J = 7 . 7, 8 . 9 Hz, 1H, H13) , 5 . 69 (dd, J = 8 .2, 2 . 8 Hz, 1H, H3' ) , S . 67 (d, J = 6. 6 Hz, 1H, H2~3) , 4 . 94 (dd, J = 9. 9, 2 .2 Hz, 1H, H5) , 4 . 79 (dd, J = 9 . 9, 2 . 8 Hz, 1H, H2' ) , 9 . 39 (ddd, J = 11 . 0, 6 . 6, 3 . 8 Hz, 1H, H7) , 9 . 30 (d, J = 8 .2 Hz, 1H, H200c) , 4 . 19 (d, J = 8 . 2 Hz, 1H, H20~3), 3.79 (d, J = 6.6 Hz, 1H, H3), 3.79 (s, 3H, Ark), 3.57 (d, J = 4.9 Hz, 1H, 2'OH), 2.53 (ddd, J = 9.9, 14 . 4, 6. 6 Hz, 1H, H6oC) , 2 . 97 (d, J = 3 .8 Hz, 1H, 70H) , 2 .36 (s, 3H, 4Ac) , 2 . 33 (m, 2H, H14) , 2 .23 (s, 3H, lOAc) , 1 . 88 (ddd, J =
11 . 0, 14 . 4, 2 .2 Hz, 1H, H6(~) , 1 .79 (br s, 3H, MelB) , 1 . 78 (s, 1H, lOH), 1.68 (s, 3H, Mel9), 1.23 (s, 3H, Mel7), 1.14 (s, 3H, Mel6) .

EXAMPLE ~Q

OAc O O O
/ ~ N _ Onuni I °~~%
Fi OtF
B r Ftn _ O
Ac O
Preparation of N-debenzoyl-N-(9-bromobenzoyl)-3'-desphenyl-3'-(4-methoxyphenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.285 mmol) in 2 mL of THF at -45 °C was added dropwise 0.175 mL of a 1.63M solution of neuLi in hexane. After 0.5 h at -45 °C, a solution of cis-1-(4-bromobenzoyl)-3-triethylsilyloxy-4-(4-methoxyphenyl)azetidin-2-one (696 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 321 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-(4-bromobenzoyl)-3'-desphenyl-3'-(9-methoxyphenyl) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 351 mg of the mixture obtained from the previous reaction in 12 mL of acetonitrile and 0.6 mL of pyridine at 0 °C was added 1.8 mL of 98% aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 320 mg of material which was purified by flash chromatography to give 189 mg (695) of N-debenzoyl-N-(4-bromobenzoyl)-3'-desphenyl-3'-(9-methoxyphenyl) taxol, which was recrystallized from methanol/water.
m.p. 173.5-176 °C: [a]ZSN, -48.9° (c 0.0065, CHC13) .
1H NMR (CDC13, 300 MHz) 8 8.13 (d, J = 7.2 Hz, 2H, benzoate ortho) , 7 . 7-7 . 3 (m, 9H, aromatic) , 6. 93 (d, J = 8 . 8, Hz, 2H, aromatic), 6.93 (d, J = 9.3 Hz, 1H, NH), 6.27 (s, 1H, H10), 6.21 (dd, J = 8.8, 8.8 Hz, 1H, H13), 5.68 (m, 2H, H3', H2~3), 9.94 (dd, J = 8.8, 1.7 Hz, 1H, H5), 4.79 (dd, J = 9.9, 2.8 Hz, 1H, fit' ) , 4 . 40 (m, 1H, H7) , 4 . 31 (d, J = 8.2 Hz, 1H, H20a) , 4 . 19 (d, J = 8 . 2 Hz, lFi, H20~3) , 3 . 80 (d, J = 7 . 1 Hz, 1H, H3),3.80 (s, 3H, ArOMS). 3.51 (d, J = 4.9 Hz, 1H, 2'OH), 2.54 (m, 1H, H6a) , 2.46 (d, J = 9 .4 Hz, 1H, 70H) , 2 .37 (s, 3H, 4Ac) , 2 . 31 (m, 2H, Hl4a, H14~3) , 2 .24 (s, 3H, lOAc) , 1 . 87 (m, 1H, H6a) , 1 . 79 (br s, 3H, MelB) , 1 . 74 (s, 1H, lOH) , 1 . 68 (s, 3H, Mel9), 1.23 (s, 3H, Mel7), 1.14 (s, 3H, Mel6).

OC H.~
Ac O
~CH3)3C Ho O
Ph~ Ac0 ~~O
Preparation of N-debenzoyl-N-(4-t-butylbenzoyl)-3'-desphenyl-3'-(4-methoxyphenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -95 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 'C, a solution of cis-1-(4-t-butylbenzoyl)-3-triethylsilyloxy-4-(4-methoxyphenyl)azetidin-2-one (670 mg, 1.93 mmol) in 2 mL
of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL
of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 340 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-(4-t-butylbenzoyl)-3'-desphenyl-3'-(4-methoxyphenyl) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 340 mg (0.291 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48% aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C
for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 275 mg of material which was purified by flash chromatography to give 188 mg (70%) of N-debenzoyl-N-(4-_-DiltylbenZOyl)-3'-desphenyl-3'-(4-methoxyphenyl) taxol, which ~..~as recrystallized from methanol/water.
m.p . 134-1 85 ~C; [a] ZS~a -50. 4° (C 0.01, CHC13) .
-H rJMR (CDC13, 300 MHz) 8 8.13 (d, J = 7.1 Hz, 2H, benzoate ortho), 7.53 (m, 9H, aromatic), 6.92 (m, 2H, aromatic), 6.88 (d, J = 8 . S Hz, 1H, rrH) , 6.27 (s, 1H, H10) , 6 . 21 (dd, J = g . 8, 8 . 8 Eiz, 1H, Eil3) , 5.72 (dd, J = 8 .8, 2 .8 Hz, 1H, Ei3' ) , 5 . 67 (d, J = 7 . 1 Hz, 1H, H2~3) , 9 . 95 (dd, J = 9. $, 2 . 2 Hz, 1H, Ei5) , 4 . 74 (dd, J = 5.5, 2.8 Hz, 1H, H2'), 4.40 (ddd, J = 11.0, 6.6, 3.8 Hz, 1H, H7), 4.30 (d, J = 8.4 Hz, 1H, H20a), 4.19 (d, J = 8.4 Hz, 1H, H20(3) , 3.80 (d, J = 7. 1 Hz, 1H, H3) , 3.79 (s, 3H, Ark) , 3 . 63 (d, J = 5 . 5 Hz, 1H, 2'OH) , 2 .54 (m, 1H, H6a) , 2.46 (d, J = 3.8 Hz, 1H, 70H), 2.38 (s, 3H, 4Ac), 2.32 (m, 2Ei, H19), 2 . 23 (s, 3H, lOAc) , 1 .87 (ddd, J = 11 .0, 14 .7, 2 .2 fiz, 1H, H6~3) , 1 . 81 (br s, 3H, Mel8) , 1 .80 (s, 1H, lOH) , 1 . 68 (s, 3H, Mel9) , 1 . 30 (s, 9H, Artgu) , 1 .23 (s, 3H, Mel7 ) , 1 . 14 (s, 3H, Mel6) .

_..._ ...~_._ ~r ,.

0C H, O
Ac O
Preparation of N-debenzoyl-N-(4-methoxybenzoyl)-3'-desphenyl-3'-(4-methoxyphenyl) taxol.
To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol)) in 2 mL of THF at -95 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-1-(4-methoxybenzoyl)-3-triethylsilyloxy-4-(4-methoxyphenyl)azetidin-2-one (630 mg, 1.43 mmol) in 2 mL
of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL
of a 10~ solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 330 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-(4-methoxybenzoyl)-3'-desphenyl-3'-(9-methoxyphenyl) taxol and a small amount of the (2'S,3'R) isomer.
To a solution of 330 mg (0.289 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 98~ aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 255 mg of material which was purified by Flash chromatography to give 183 mg (705) of N-debenzoyl-N-(4-:~.ethcxybenzoyl)-3'-desphenyl-3'-(4-methoxyphenyl) taxol, which was recrystallized from methanol/water.
;n. p . 174-175 °C: [OC] zSVa -50 . 6° (c 0 . O1, CHC13) .
vH ~JMR (CDC13, 300 MHz) S 8.13 (d, J ~ 7.1 Hz, 2H, benzoate ortho), 7.69 (d, J = 8.8 Hz, 2H, benzamide ortho), 7.62 (m, 1H, aromatic), 7.51 (m, 2H, aromatic), 7.39 (m, 2H, aromatic), 6.90 (m, 9H, aromatic) , 6. 82 (d, J = 8 .2 Hz, 1H, NH) , 6. 27 (s, 1H, H10), 6.20 (dd, J = 8.8, 8.8 Hz, 1H, H13), 5.69 (dd, J = 8.2, 2 . 7 Hz, 1H, H3' ) , 5. 67 (d, J = 6. 6 Hz, 1H, H2~3) , 4 . 95 (dd, J =
7 . 7, 1 . 6 Hz, 1H, H5) , 9 .73 (dd, J = 5.5, 2 .7 Hz, 1H, H2' ) , 4 . 40 (ddd, J = 11.0, 6.6, 4.9 Hz, 1H, H7), 4.30 (d, J = 8.24 Hz, 1H, H20ot) , 4 . 19 (d, J = 8.24 Hz, 1H, H20p) , 3 .81 (s, 3H, ArQ~) , 3 . 80 (d, J = 6. 6 Hz, 1H, H3) , 3. 78 (s, 3H, Ark) , 3 . 71 (d, J = 5. 5 fiz, 1H, 2'OH) , 2.54 (ddd, J = 7 .7, 14 .3, 6. 6 Hz, 1H, H60c) , 2 . 97 (d, J = 4 .4 Hz, 1H, 70H) , 2.37 (s, 3H, 4Ac) , 2.31 (m, 2H, H14), 2.23 (s, 3H, lOAc), 1.89 (ddd, J = 11.0, 14 . 3, 1 . 6 Hz, 1H, H6(3) , 1 .79 (br s, 3H, MelB) , 1 . 69 (s, lEi, lOH) , 1 . 67 (s, 3H, Mel9) , 1 .23 (s, 3H, Mel7) , 1 . 13 (s, 3Ei, Mel6) .

Tubulin binding assays were performed using compounds from the previous Examples substantially as set forth in Parness et al., J_Cell BiolOgY 91: 479-487 (1981) and compared to taxol and taxotere. The results are presented in Table 1.

Tubulin Assay Init. Rel.
Comeound Peak Ra Example 1 0 0 60 f33 Taxol 100 98 Taxotere 100 IC50 data were obtained in vitro on a human cancer cell line (HCT 116) which is available from the National Cancer Institute, and a multidrug resistant cell line (HCT/VM46), which is resistant to a variety of hydrophobic agents, including taxol. Cytotoxicity was assessed in fiCT116 and PICT VM46 human colon carcinoma cells by XTT (2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl. J-2tt-t_etrazol.ium I~ydroxic9e assay (Scudi.ero et al, "Evaluation of_ a soluble t~etrazoliam/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines", Cancer Res 48:9827-4833, 1988).
Cells were plated at 4000 cells/well in 96 well microtiter plates and 24 hours later drugs were added and serial diluted. The cells were incubated at 37°C for 72 hours at which time the tetrazolium dye, XTT, was added. A
dehydrogenase enzyme in live cells reduces the XTT to a form that absorbs light at 450 nm which can be quantitated spectrophotometrically. The greater the absorbance the greater the number of live cells. The results are expressed as an IC50 which is the drug concentration required to inhibit cell proliferation (i.e. absorbance at 950 nrn) to 50% of that of untreated control cells. The results are presented in Table 2. Lower numbers indicate greater activity.

HCT HCT

Compound 116 VM46 Example 1 .385 2.58 2 .084 1.89 3 .005 0.469 4 .018 0.825 .025 1.38 6 .021 1.7 7 .303 X7.8 8 .014 2.6 9 .014 0.817 .009 2.26 11 .014 1.85 12 .005 0.442 13 .006 0.651 14 .004 0.973 .005 2.17 Taxol 0.004 0.536 Taxotere 0.007 0.246 In view of the above, it will be seen that the several objects are achieved.
As various changes could be made in the above compositions without departing from f:he scope of the invention, it is intended that all matter contained in the above description be interpreted as illustrative and not in a limiting sense.

Claims (28)

CLAIMS:
1. A .beta.-lactam of the formula wherein R1 and R3 are independently selected from phenyl, naphthyl , C6H5CHCH- , and Q i s NO2 ; and R2 is hydrogen or hydroxy protecting group.
2. A .beta.-lactam of the formula wherein R1 is selected from phenyl, naphthyl, C6H5CHCH-, and R3 is selected from naphthyl, C6H5CHCH-, and Q i s NO2; and R2 is hydrogen or hydroxy protecting group.
3. A .beta.-lactam of the formula wherein R1 is selected from naphthyl, C6H5CHCH-, and R3 is selected from phenyl, naphthyl, C6H5CHCH-, and Q i s NO2 ; and R2 is hydrogen or hydroxy protecting group.
4. A .beta.-lactam of the formula wherein R1 is selected from naphthyl, C6H5CHCH-, and R3 is selected from phenyl, naphthyl, C6H5CHCH-, and Q i s NO2 ; and R2 is hydrogen or hydroxy protecting group.
5. A .beta.-lactam of the formula wherein R1 and R3 are independently selected from phenyl, naphthyl, C6H5CHCH-, and Q is-Cl, Br, or F; and R2 is hydrogen or hydroxy protecting group.
6. A .beta.-lactam of the formula wherein R1 is selected from phenyl, naphthyl, C6H5CHCH-, and R3 is selected from naphthyl, C6H5CHCH-, and Q is C1, Br, or F; and R2 is hydrogen or hydroxy protecting group.
7. A .beta.-lactam of the formula wherein R1 is selected from naphthyl, C6H5CHCH-, and R3 is selected from phenyl, naphthyl, C6H5CHCH-, and Q is C1, Br, F; and R2 is hydrogen or hydroxy protecting group.
8. A .beta.-lactam of the formula wherein R1 is selected from naphthyl, C6H5CHCH-, and R3 is selected from phenyl, naphthyl, C6H5CHCH-, and Q is C1, Br, F; and R2 is hydrogen or hydroxy protecting group.
9. A .beta.-lactam of the formula wherein R1 is selected from phenyl, naphthyl, C6H5CHCH-, and R3 is selected from naphthyl, C6H5CHCH-, and Q is CH3-, (CH3) 3C-, CH3O-, C1, Br, F, or NO2; and R2 is hydrogen or hydroxy protecting group.
10. A .beta.-lactam of the formula wherein R1 is selected from C6H5CHCH-, and R3 is selected from phenyl, naphthyl, C6H5CHCH-, and Q is CH3-, (CH3) 3C-, CH3O-, C1, Br, F, or NO2; and R2 is hydrogen or hydroxy protecting group.
11. A .beta.-lactam of the formula wherein R1 is R3 is selected from phenyl, naphthyl, C6H5CHCH-, and Q is Cl, Br, or F; and R2 is hydrogen or hydroxy protecting group.
12. A .beta.-lactam of the formula wherein R1 is R3 is selected from naphthyl, C6H5CHCH-, and Q is Cl, Br, or F; and R2 is hydrogen or hydroxy protecting group.
13. A .beta.-lactam of the formula wherein R1 is selected from phenyl, naphthyl, C6H5CHCH-, and R3 is Q is Cl, Br, or F; and R2 is hydrogen or hydroxy protecting group.
14. A .beta.-lactam of the formula wherein R1 is selected from naphthyl, C6H5CHCH-, and R3 is Q is C1, Br, or F; and R2 is hydrogen or hydroxy protecting group.
15. A .beta.-lactam of the formula wherein R1 is selected from naphthyl, C6H5CHCH-, and R3 is Q is Cl, Br, or F; and R2 is hydrogen or hydroxy protecting group.
16. A .beta.-lactam of the formula wherein R1 is R3 is selected from phenyl, naphthyl, C6H5CHCH-, and Q is NO2; and R2 is hydrogen or hydroxy protecting group.
17. A .beta.-lactam of the formula wherein R1 is R3 is selected from naphthyl, C6H5CHCH-, and Q is NO2; and R2 is hydrogen or hydroxy protecting group.
18. A .beta.-lactam of the formula wherein R1 is selected from phenyl, naphthyl, C6H5CHCH-, and R3 is Q i s NO2; and R2 is hydrogen or hydroxy protecting group.
19. A .beta.-lactam of the formula wherein R1 is selected from naphthyl, C6H5CHCH-, and R3 is Q i s NO2; and R2 is hydrogen or hydroxy protecting group.
20. A .beta.-lactam of the formula wherein R1 is selected from naphthyl, C6H5CHCH-, and R3 is Q i s NO2; and R2 is hydrogen or hydroxy protecting group.
21. A process for the preparation of a .beta.-lactam of the formula or an enantiomer or diastereoisomer thereof, which process comprises cyclocondensing a compound having the structure with an imine having the structure to form an azetidine having the structure treating said azetidine with an acyl chloride of formula R3C(C)Cl in the presence of a base to form the .beta.-lactam of formula (4), wherein R1 and R3 are independently selected from phenyl, naphthyl, C6H5CHCH-, and Q is CH3-, (CH3)3C-, CH3O-, Cl, Br, F, or NO2; and R2 is hydrogen or hydroxy protecting group;
R11 is trialkylsilyl or triarylsilyl;
R22 is alkyl; and M is a metal.
22. The process of claim 21, wherein R2 is trialkylsilyl or triarylsilyl; R11 is trimethylsilyl; R22 is ethyl; and M is lithium.
23. The process of claim 21 or 22, wherein R3 is selected from the group comprising naphthyl, C6H5CHCH-, and
24. The process of claim 21 or 22, wherein R1 is selected from the group comprising C6H5CHCH-, and
25. The process of claim 21 or 22, wherein R1 is and Q is Cl, Br or F.
26. The process of claim 21 or 22, wherein R3 is and Q is Cl, Br or F.
27. The process of claim 21 or 22, wherein R1 is and Q i s -NO2.
28. The process of claim 21 or 22, wherein R3 is and Q i s -NO2.
CA002221190A 1991-09-23 1992-09-02 Novel substituted taxanes and pharmaceutical compositions containing them Expired - Fee Related CA2221190C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US76380591A 1991-09-23 1991-09-23
US07/763,805 1991-09-23
US07/863,451 US5250683A (en) 1991-09-23 1992-04-03 Certain substituted taxanes and pharmaceutical compositions containing them
US07/863,451 1992-04-03
CA002077394A CA2077394C (en) 1991-09-23 1992-09-02 Substituted taxanes and pharmaceutical compositions containing them

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002077394A Division CA2077394C (en) 1991-09-23 1992-09-02 Substituted taxanes and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
CA2221190A1 CA2221190A1 (en) 1993-03-24
CA2221190C true CA2221190C (en) 2002-02-12

Family

ID=27117342

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002221190A Expired - Fee Related CA2221190C (en) 1991-09-23 1992-09-02 Novel substituted taxanes and pharmaceutical compositions containing them
CA002077394A Expired - Fee Related CA2077394C (en) 1991-09-23 1992-09-02 Substituted taxanes and pharmaceutical compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002077394A Expired - Fee Related CA2077394C (en) 1991-09-23 1992-09-02 Substituted taxanes and pharmaceutical compositions containing them

Country Status (14)

Country Link
US (1) US5250683A (en)
EP (1) EP0534709B1 (en)
JP (1) JP3182231B2 (en)
AT (1) ATE231139T1 (en)
AU (1) AU655493B2 (en)
CA (2) CA2221190C (en)
DE (1) DE69232895T2 (en)
DK (1) DK0534709T3 (en)
ES (1) ES2191005T3 (en)
FI (1) FI113173B (en)
HU (1) HU215110B (en)
MX (1) MX9205311A (en)
NO (1) NO305205B1 (en)
NZ (1) NZ244457A (en)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739362A (en) * 1991-09-23 1998-04-14 Florida State University Taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them
US6028205A (en) * 1991-09-23 2000-02-22 Florida State University C2 tricyclic taxanes
US5243045A (en) * 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
US6011056A (en) 1991-09-23 2000-01-04 Florida State University C9 taxane derivatives and pharmaceutical compositions containing them
US5714513A (en) * 1991-09-23 1998-02-03 Florida State University C10 taxane derivatives and pharmaceutical compositions
US5489601A (en) * 1991-09-23 1996-02-06 Florida State University Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
US5654447A (en) * 1991-09-23 1997-08-05 Florida State University Process for the preparation of 10-desacetoxybaccatin III
ZA926827B (en) * 1991-09-23 1993-03-15 Univ Florida State Novel furyl and thienyl substituted taxanes and pharmaceutical compositions containing them.
US5721268A (en) 1991-09-23 1998-02-24 Florida State University C7 taxane derivatives and pharmaceutical compositions containing them
US5998656A (en) * 1991-09-23 1999-12-07 Florida State University C10 tricyclic taxanes
US6018073A (en) * 1991-09-23 2000-01-25 Florida State University Tricyclic taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them
US6005138A (en) * 1991-09-23 1999-12-21 Florida State University Tricyclic taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them
US6495704B1 (en) 1991-09-23 2002-12-17 Florida State University 9-desoxotaxanes and process for the preparation of 9-desoxotaxanes
US5728725A (en) * 1991-09-23 1998-03-17 Florida State University C2 taxane derivaties and pharmaceutical compositions containing them
US5710287A (en) * 1991-09-23 1998-01-20 Florida State University Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them
US6335362B1 (en) 1991-09-23 2002-01-01 Florida State University Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
US5728850A (en) * 1991-09-23 1998-03-17 Florida State University Taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
ES2149800T3 (en) * 1992-01-15 2000-11-16 Squibb & Sons Inc ENZYMATIC PROCEDURES FOR THE RESOLUTION OF ENANTIOMERIC MIXTURES OF COMPOUNDS USEFUL AS INTERMEDIARIES IN THE PREPARATION OF TAXANES.
US5294637A (en) * 1992-07-01 1994-03-15 Bristol-Myers Squibb Company Fluoro taxols
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
FR2696461B1 (en) * 1992-10-05 1994-11-10 Rhone Poulenc Rorer Sa New derivatives of taxol analogs, their preparation and compositions containing them.
US5380751A (en) * 1992-12-04 1995-01-10 Bristol-Myers Squibb Company 6,7-modified paclitaxels
FR2698871B1 (en) 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa New taxoids, their preparation and the pharmaceutical compositions containing them.
IL107950A (en) 1992-12-15 2001-04-30 Upjohn Co 7β, 8β - METHANO-TAXOLS, THEIR PREPARATION AND ANTINEOPLASTIC PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US5646176A (en) 1992-12-24 1997-07-08 Bristol-Myers Squibb Company Phosphonooxymethyl ethers of taxane derivatives
IL108316A (en) * 1993-01-15 2006-10-31 Univ Florida State C10 taxane derivatives and pharmaceutical compositions containing them
US6066747A (en) * 1993-03-05 2000-05-23 Florida State University Process for the preparation of 9-desoxotaxanes
US6710191B2 (en) * 1993-03-05 2004-03-23 Florida State University 9β-hydroxytetracyclic taxanes
TW467896B (en) 1993-03-19 2001-12-11 Bristol Myers Squibb Co Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes
AU6367994A (en) * 1993-03-22 1994-10-11 Florida State University Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same
IT1261667B (en) * 1993-05-20 1996-05-29 TAX FOR ANTI-CANCER ACTIVITIES.
WO1994029288A1 (en) * 1993-06-11 1994-12-22 The Upjohn Company Δ6,7-taxols antineoplastic use and pharmaceutical compositions containing them
TW397866B (en) 1993-07-14 2000-07-11 Bristol Myers Squibb Co Enzymatic processes for the resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes
IL112412A (en) * 1994-01-28 2000-02-29 Upjohn Co Delta 12,13-iso-taxol analogs and antineoplastic pharmaceutical compositions containing them
AU726730B2 (en) * 1994-01-28 2000-11-16 Pharmacia & Upjohn Company Delta 12,13-iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them
GB9405400D0 (en) * 1994-03-18 1994-05-04 Erba Carlo Spa Taxane derivatives
US6201140B1 (en) 1994-07-28 2001-03-13 Bristol-Myers Squibb Company 7-0-ethers of taxane derivatives
US5780653A (en) * 1995-06-07 1998-07-14 Vivorx Pharmaceuticals, Inc. Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers
AU728057B2 (en) * 1995-09-13 2001-01-04 Florida State University Radiosensitizing taxanes and their pharmaceutical preparations
CN1211919A (en) 1995-09-13 1999-03-24 佛罗里达州立大学 Radiosensitizing taxanes and their pharmaceutical preparations
US5840748A (en) * 1995-10-02 1998-11-24 Xechem International, Inc. Dihalocephalomannine and methods of use therefor
US5807888A (en) * 1995-12-13 1998-09-15 Xechem International, Inc. Preparation of brominated paclitaxel analogues and their use as effective antitumor agents
US5654448A (en) * 1995-10-02 1997-08-05 Xechem International, Inc. Isolation and purification of paclitaxel from organic matter containing paclitaxel, cephalomannine and other related taxanes
US5854278A (en) * 1995-12-13 1998-12-29 Xechem International, Inc. Preparation of chlorinated paclitaxel analogues and use thereof as antitumor agents
US6177456B1 (en) 1995-10-02 2001-01-23 Xechem International, Inc. Monohalocephalomannines having anticancer and antileukemic activity and method of preparation therefor
CA2253513A1 (en) 1996-05-06 1997-11-13 Florida State University 1-deoxy baccatin iii, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof
AU4768797A (en) 1996-10-24 1998-05-15 Institute Armand-Frappier A family of canadensol taxanes, the semi-synthetic preparation and therapeutic use thereof
US6103698A (en) 1997-03-13 2000-08-15 Basf Aktiengesellschaft Dolastatin-15 derivatives in combination with taxanes
JPH1192468A (en) * 1997-09-17 1999-04-06 Yakult Honsha Co Ltd New taxane derivative
KR100551945B1 (en) * 1997-12-19 2006-02-20 가부시키가이샤 야쿠루트 혼샤 Taxane derivatives
US6156789A (en) * 1998-03-17 2000-12-05 Rhone-Poulenc Rorer S.A. Method for treating abnormal cell proliferation in the brain
US6136988A (en) 1998-04-10 2000-10-24 Hauser, Inc. 7-hexanoyltaxol and methods for preparing the same
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6649632B2 (en) * 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
TR200102858T1 (en) * 2000-02-02 2002-12-23 Florida State University Research Foundation, Inc C10 ester substituted taxanes as antitumor agents
CZ20013519A3 (en) 2000-02-02 2002-04-17 Florida State University Research Foundation, Inc. Taxanes with C7 hetero substituted acetate functioning as antitumor agents
BR0104358A (en) * 2000-02-02 2002-01-02 Univ Florida State Res Found Taxane formulations having improved solubility
PL350075A1 (en) * 2000-02-02 2002-11-04 Univ Florida State Res Found Taxane formulations having improved solubility
DE10032256C2 (en) * 2000-07-03 2003-06-05 Infineon Technologies Ag Chip ID register configuration
CA2354471A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C10 ester substituted taxanes
SG129990A1 (en) * 2001-08-01 2007-03-20 Univ Florida State Res Found C10 ester substituted taxanes
AU2002365883A1 (en) * 2001-11-30 2003-06-17 Bristol-Myers Squibb Company Paclitaxel solvates
WO2003085110A2 (en) 2002-04-05 2003-10-16 Santaris Pharma A/S Oligomeric compounds for the modulation hif-1alpha expression
US7713738B2 (en) 2003-02-10 2010-05-11 Enzon Pharmaceuticals, Inc. Oligomeric compounds for the modulation of survivin expression
US7064980B2 (en) * 2003-09-17 2006-06-20 Sandisk Corporation Non-volatile memory and method with bit line coupled compensation
US7622453B2 (en) 2003-12-23 2009-11-24 Santaris Pharma A/S Oligomeric compounds for the modulation of Bcl-2
HN2005000054A (en) * 2004-02-13 2009-02-18 Florida State University Foundation Inc REPLACED TAXANS WITH CYCLOPENTILO ESTERS IN C10
MX2007005558A (en) * 2004-11-09 2008-01-31 Santaris Pharma As Potent lna oligonucleotides for the inhibition of hif-1a expression.
MX2007005557A (en) * 2004-11-09 2008-02-15 Santaris Pharma As Lna oligonucleotides and the treatment of cancer.
US9447138B2 (en) 2004-11-09 2016-09-20 Roche Innovation Center Copenhagen A/S Potent LNA oligonucleotides for the inhibition of HIF-1a expression
US7754850B2 (en) 2005-02-11 2010-07-13 University Of Southern California Chimeric disintegrin domain
MX2007009748A (en) * 2005-02-14 2007-09-26 Univ Florida State Res Found C10 cyclopropyl ester substituted taxane compositions.
EP2029156A4 (en) * 2006-05-01 2010-07-21 Univ Southern California Combination therapy for treatment of cancer
JP2011517455A (en) * 2008-03-31 2011-06-09 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド C (10) ethyl ester and C (10) cyclopropyl ester substituted taxanes
WO2010056901A2 (en) 2008-11-13 2010-05-20 University Of Southern California Method of expressing proteins with disulfide bridges with enhanced yields and activity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601676B1 (en) * 1986-07-17 1988-09-23 Rhone Poulenc Sante PROCESS FOR THE PREPARATION OF TAXOL AND DESACETYL-10 TAXOL
FR2601675B1 (en) * 1986-07-17 1988-09-23 Rhone Poulenc Sante TAXOL DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US4942184A (en) * 1988-03-07 1990-07-17 The United States Of America As Represented By The Department Of Health And Human Services Water soluble, antineoplastic derivatives of taxol
FR2629819B1 (en) * 1988-04-06 1990-11-16 Rhone Poulenc Sante PROCESS FOR THE PREPARATION OF BACCATIN III AND DESACETYL-10 BACCATIN III DERIVATIVES
FR2629818B1 (en) * 1988-04-06 1990-11-16 Centre Nat Rech Scient PROCESS FOR THE PREPARATION OF TAXOL
US4960790A (en) * 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5015744A (en) * 1989-11-14 1991-05-14 Florida State University Method for preparation of taxol using an oxazinone
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
MX9102128A (en) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa DERIVATIVES OF TAXANE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM

Also Published As

Publication number Publication date
FI924228A0 (en) 1992-09-21
HUT63155A (en) 1993-07-28
DE69232895T2 (en) 2003-07-31
ES2191005T3 (en) 2003-09-01
AU2212492A (en) 1993-03-25
ATE231139T1 (en) 2003-02-15
EP0534709A1 (en) 1993-03-31
CA2077394A1 (en) 1993-03-24
CA2077394C (en) 1999-04-06
JPH06199824A (en) 1994-07-19
JP3182231B2 (en) 2001-07-03
HU9203024D0 (en) 1992-12-28
NO923679L (en) 1993-03-24
AU655493B2 (en) 1994-12-22
FI924228A (en) 1993-03-24
NO305205B1 (en) 1999-04-19
NZ244457A (en) 1995-03-28
EP0534709B1 (en) 2003-01-15
HU215110B (en) 1998-12-28
CA2221190A1 (en) 1993-03-24
NO923679D0 (en) 1992-09-22
US5250683A (en) 1993-10-05
DE69232895D1 (en) 2003-02-20
DK0534709T3 (en) 2003-05-12
FI113173B (en) 2004-03-15
MX9205311A (en) 1993-07-01

Similar Documents

Publication Publication Date Title
CA2221190C (en) Novel substituted taxanes and pharmaceutical compositions containing them
CA2077621C (en) Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5243045A (en) Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
US5283253A (en) Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
US5284864A (en) Butenyl substituted taxanes and pharmaceutical compositions containing them
CA2158454C (en) Taxanes having furyl or thienyl substituted side-chain
US5728725A (en) C2 taxane derivaties and pharmaceutical compositions containing them
AU689099B2 (en) C7 taxane derivatives and pharmaceutical compositions containing them
CA2147984C (en) Butenyl-substituted taxanes and composition
CA2155013C (en) C2 taxane derivatives and pharmaceutical compositions containing them
US6028205A (en) C2 tricyclic taxanes
AU702492B2 (en) Beta-lactams useful in the preparation of taxanes having a pyridyl substituted side-chain

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed